Wikipedia
gpewiki
https://gpe.wikipedia.org/wiki/Main_Page
MediaWiki 1.47.0-wmf.24
first-letter
Media
Special
Talk
User
User talk
Wikipedia
Wikipedia talk
File
File talk
MediaWiki
MediaWiki talk
Template
Template talk
Help
Help talk
Category
Category talk
TimedText
TimedText talk
Module
Module talk
Event
Event talk
Benzonatate
0
31032
114922
114897
2026-10-16T16:13:53Z
DaSupremo
9
Improve article
114922
wikitext
text/x-wiki
{{Databox}}
'''Benzonatate''' ({{IPAc-en|b|ɛ|n|ˈ|z|oʊ|n|ə|t|eɪ|t}}), dem sell under de brand name '''Tessalon''' among odas, be a medication wey be used for de symptomatic relief of [[cough]].<ref name=AHFS2019>{{cite web |title=Benzonatate Monograph for Professionals |url=https://www.drugs.com/monograph/benzonatate.html |website=Drugs.com |publisher=American Society of Health-System Pharmacists |access-date=23 March 2019 }}</ref><ref name=Bec2010>{{cite journal | vauthors = Becker DE | title = Nausea, vomiting, and hiccups: a review of mechanisms and treatment | journal = Anesthesia Progress | volume = 57 | issue = 4 | pages = 150–6; quiz 157 | date = 2010 | pmid = 21174569 | pmc = 3006663 | doi = 10.2344/0003-3006-57.4.150 }}</ref> Dem dey take benzonatate [[oral administration|by mouth]].<ref name=AHFS2019/><ref name="Homsi20012">{{cite journal |vauthors=Homsi J, Walsh D, Nelson KA |date=November 2001 |title=Important drugs for cough in advanced cancer |journal=Supportive Care in Cancer |volume=9 |issue=8 |pages=565–574 |doi=10.1007/s005200100252 |pmid=11762966 |s2cid=25881426}}</ref> Effects generally dey begin within 20{{nbsp}}minutes den dey last between 3 den 8{{nbsp}}hours.<ref name=AHFS2019/><ref name="Tessalon label2">{{cite web |date=20 November 2019 |title=Tessalon - benzonatate capsule |url=https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8edd07a0-5f5b-9000-bafb-dbf8ff7609d4 |access-date=21 April 2020 |website=DailyMed}}</ref>
[[Side effect]]s dey include sleepiness, [[dizziness]], [[headache]], [[upset stomach]], [[skin rash]], [[hallucination]]s, den allergic reactions.<ref name=AHFS2019/> [[Drug overdose|Overdosage]] fi result in serious [[adverse effect]]s wey dey include [[seizures]], [[irregular heartbeat]], [[cardiac arrest]], den death.<ref name="pmid34219543" /> Overdose of only a small number of capsules fi be fatal.<ref name="pmid34219543">{{cite journal | vauthors = Minhaj FS, Leonard JB | title = A description of the clinical course of severe benzonatate poisonings reported in the literature and to NPDS: A systematic review supplemented with NPDS cases | journal = Hum Exp Toxicol | volume = 40 | issue = 12_suppl | pages = S39–S48 | date = December 2021 | pmid = 34219543 | doi = 10.1177/09603271211030560 | bibcode = 2021HETox..40S..39M | s2cid = 235735410 | url = }}</ref> Chewing or sucking on the capsule, releasing the drug into the mouth, can also lead to [[laryngospasm]], [[bronchospasm]], and [[circulatory collapse]].<ref name=AHFS2019/> E be unclear if ein use insyd [[pregnancy]] anaa [[breastfeeding]] while on de medication be safe.<ref name=Preg2020>{{cite web|url=https://www.drugs.com/pregnancy/benzonatate.html|title=Benzonatate Use During Pregnancy|date=10 October 2019|website=Drugs.com|access-date=20 February 2020}}</ref> Benzonatate be a [[local anesthetic]] den [[voltage-gated sodium channel]] [[sodium channel blocker|blocker]]. E be theorized to work by inhibiting [[pulmonary stretch receptor|stretch receptors insyd de lungs]], in turn dey suppress de [[cough reflex]] insyd de brain.<ref name="AHFS2019" /> Benzonatate be [[structural analog|structurally related]] to oda local anesthetics like [[procaine]] den [[tetracaine]].<ref name=AHFS2019/>
== References ==
<references />
== External links ==
[[Category:Translated from MDWiki]]
870frtc26s14vpnrb3c9vv6adplk18t
114923
114922
2026-10-16T16:18:40Z
DaSupremo
9
Add references
114923
wikitext
text/x-wiki
{{Databox}}
'''Benzonatate''' ({{IPAc-en|b|ɛ|n|ˈ|z|oʊ|n|ə|t|eɪ|t}}), dem sell under de brand name '''Tessalon''' among odas, be a medication wey be used for de symptomatic relief of [[cough]].<ref name=AHFS2019>{{cite web |title=Benzonatate Monograph for Professionals |url=https://www.drugs.com/monograph/benzonatate.html |website=Drugs.com |publisher=American Society of Health-System Pharmacists |access-date=23 March 2019 }}</ref><ref name=Bec2010>{{cite journal | vauthors = Becker DE | title = Nausea, vomiting, and hiccups: a review of mechanisms and treatment | journal = Anesthesia Progress | volume = 57 | issue = 4 | pages = 150–6; quiz 157 | date = 2010 | pmid = 21174569 | pmc = 3006663 | doi = 10.2344/0003-3006-57.4.150 }}</ref> Dem dey take benzonatate [[oral administration|by mouth]].<ref name=AHFS2019/><ref name="Homsi20012">{{cite journal |vauthors=Homsi J, Walsh D, Nelson KA |date=November 2001 |title=Important drugs for cough in advanced cancer |journal=Supportive Care in Cancer |volume=9 |issue=8 |pages=565–574 |doi=10.1007/s005200100252 |pmid=11762966 |s2cid=25881426}}</ref> Effects generally dey begin within 20{{nbsp}}minutes den dey last between 3 den 8{{nbsp}}hours.<ref name=AHFS2019/><ref name="Tessalon label2">{{cite web |date=20 November 2019 |title=Tessalon - benzonatate capsule |url=https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8edd07a0-5f5b-9000-bafb-dbf8ff7609d4 |access-date=21 April 2020 |website=DailyMed}}</ref>
[[Side effect]]s dey include sleepiness, [[dizziness]], [[headache]], [[upset stomach]], [[skin rash]], [[hallucination]]s, den allergic reactions.<ref name=AHFS2019/> [[Drug overdose|Overdosage]] fi result in serious [[adverse effect]]s wey dey include [[seizures]], [[irregular heartbeat]], [[cardiac arrest]], den death.<ref name="ML2018">{{cite journal |vauthors= |date=December 2018 |title=Drugs for cough |journal=The Medical Letter on Drugs and Therapeutics |volume=60 |issue=1562 |pages=206–208 |pmid=30625123}}</ref><ref name="pmid34219543" /> Overdose of only a small number of capsules fi be fatal.<ref name="pmid34219543">{{cite journal | vauthors = Minhaj FS, Leonard JB | title = A description of the clinical course of severe benzonatate poisonings reported in the literature and to NPDS: A systematic review supplemented with NPDS cases | journal = Hum Exp Toxicol | volume = 40 | issue = 12_suppl | pages = S39–S48 | date = December 2021 | pmid = 34219543 | doi = 10.1177/09603271211030560 | bibcode = 2021HETox..40S..39M | s2cid = 235735410 | url = }}</ref> Chewing or sucking on the capsule, releasing the drug into the mouth, can also lead to [[laryngospasm]], [[bronchospasm]], and [[circulatory collapse]].<ref name=AHFS2019/> E be unclear if ein use insyd [[pregnancy]] anaa [[breastfeeding]] while on de medication be safe.<ref name=Preg2020>{{cite web|url=https://www.drugs.com/pregnancy/benzonatate.html|title=Benzonatate Use During Pregnancy|date=10 October 2019|website=Drugs.com|access-date=20 February 2020}}</ref> Benzonatate be a [[local anesthetic]] den [[voltage-gated sodium channel]] [[sodium channel blocker|blocker]].<ref>{{Cite web |title=Benzonatate |url=https://go.drugbank.com/drugs/DB00868 |access-date=2026-10-16 |website=go.drugbank.com |language=en}}</ref> E be theorized to work by inhibiting [[pulmonary stretch receptor|stretch receptors insyd de lungs]], in turn dey suppress de [[cough reflex]] insyd de brain.<ref name="AHFS2019" /> Benzonatate be [[structural analog|structurally related]] to oda local anesthetics like [[procaine]] den [[tetracaine]].<ref name=AHFS2019/><ref name="pmid18771744">{{cite journal |vauthors=Dicpinigaitis PV |date=April 2009 |title=Currently available antitussives |url= |journal=Pulm Pharmacol Ther |volume=22 |issue=2 |pages=148–51 |doi=10.1016/j.pupt.2008.08.002 |pmid=18771744}}</ref>
== References ==
<references />
== External links ==
[[Category:Translated from MDWiki]]
5v9r3d8fc78hu3rpdl6bf1r3k7x9t8b
114924
114923
2026-10-16T16:34:12Z
DaSupremo
9
Improve article
114924
wikitext
text/x-wiki
{{Databox}}
'''Benzonatate''' ({{IPAc-en|b|ɛ|n|ˈ|z|oʊ|n|ə|t|eɪ|t}}), dem sell under de brand name '''Tessalon''' among odas, be a medication wey be used for de symptomatic relief of [[cough]].<ref name=AHFS2019>{{cite web |title=Benzonatate Monograph for Professionals |url=https://www.drugs.com/monograph/benzonatate.html |website=Drugs.com |publisher=American Society of Health-System Pharmacists |access-date=23 March 2019 }}</ref><ref name=Bec2010>{{cite journal | vauthors = Becker DE | title = Nausea, vomiting, and hiccups: a review of mechanisms and treatment | journal = Anesthesia Progress | volume = 57 | issue = 4 | pages = 150–6; quiz 157 | date = 2010 | pmid = 21174569 | pmc = 3006663 | doi = 10.2344/0003-3006-57.4.150 }}</ref> Dem dey take benzonatate [[oral administration|by mouth]].<ref name=AHFS2019/><ref name="Homsi20012">{{cite journal |vauthors=Homsi J, Walsh D, Nelson KA |date=November 2001 |title=Important drugs for cough in advanced cancer |journal=Supportive Care in Cancer |volume=9 |issue=8 |pages=565–574 |doi=10.1007/s005200100252 |pmid=11762966 |s2cid=25881426}}</ref> Effects generally dey begin within 20{{nbsp}}minutes den dey last between 3 den 8{{nbsp}}hours.<ref name=AHFS2019/><ref name="Tessalon label2">{{cite web |date=20 November 2019 |title=Tessalon - benzonatate capsule |url=https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8edd07a0-5f5b-9000-bafb-dbf8ff7609d4 |access-date=21 April 2020 |website=DailyMed}}</ref>
[[Side effect]]s dey include sleepiness, [[dizziness]], [[headache]], [[upset stomach]], [[skin rash]], [[hallucination]]s, den allergic reactions.<ref name=AHFS2019/> [[Drug overdose|Overdosage]] fi result in serious [[adverse effect]]s wey dey include [[seizures]], [[irregular heartbeat]], [[cardiac arrest]], den death.<ref name="ML2018">{{cite journal |vauthors= |date=December 2018 |title=Drugs for cough |journal=The Medical Letter on Drugs and Therapeutics |volume=60 |issue=1562 |pages=206–208 |pmid=30625123}}</ref><ref name="pmid34219543" /> Overdose of only a small number of capsules fi be fatal.<ref name="pmid34219543">{{cite journal | vauthors = Minhaj FS, Leonard JB | title = A description of the clinical course of severe benzonatate poisonings reported in the literature and to NPDS: A systematic review supplemented with NPDS cases | journal = Hum Exp Toxicol | volume = 40 | issue = 12_suppl | pages = S39–S48 | date = December 2021 | pmid = 34219543 | doi = 10.1177/09603271211030560 | bibcode = 2021HETox..40S..39M | s2cid = 235735410 | url = }}</ref> Chewing or sucking on the capsule, releasing the drug into the mouth, can also lead to [[laryngospasm]], [[bronchospasm]], and [[circulatory collapse]].<ref name=AHFS2019/> E be unclear if ein use insyd [[pregnancy]] anaa [[breastfeeding]] while on de medication be safe.<ref name=Preg2020>{{cite web|url=https://www.drugs.com/pregnancy/benzonatate.html|title=Benzonatate Use During Pregnancy|date=10 October 2019|website=Drugs.com|access-date=20 February 2020}}</ref> Benzonatate be a [[local anesthetic]] den [[voltage-gated sodium channel]] [[sodium channel blocker|blocker]].<ref>{{Cite web |title=Benzonatate |url=https://go.drugbank.com/drugs/DB00868 |access-date=2026-10-16 |website=go.drugbank.com |language=en}}</ref> E be theorized to work by inhibiting [[pulmonary stretch receptor|stretch receptors insyd de lungs]], in turn dey suppress de [[cough reflex]] insyd de brain.<ref name="AHFS2019" /> Benzonatate be [[structural analog|structurally related]] to oda local anesthetics like [[procaine]] den [[tetracaine]].<ref name=AHFS2019/><ref name="pmid18771744">{{cite journal |vauthors=Dicpinigaitis PV |date=April 2009 |title=Currently available antitussives |url= |journal=Pulm Pharmacol Ther |volume=22 |issue=2 |pages=148–51 |doi=10.1016/j.pupt.2008.08.002 |pmid=18771744}}</ref>
Na dem discover benzonatate insyd 1956 wey na dem approve am for medical use insyd de [[United States]] insyd 1958.<ref name=AHFS2019/><ref name="Homsi2001">{{cite journal |vauthors=Homsi J, Walsh D, Nelson KA |date=November 2001 |title=Important drugs for cough in advanced cancer |journal=Supportive Care in Cancer |volume=9 |issue=8 |pages=565–574 |doi=10.1007/s005200100252 |pmid=11762966 |s2cid=25881426}}</ref> E be available as a [[generic medication]].<ref name=ML2018>{{cite journal | vauthors = | title = Drugs for cough | journal = The Medical Letter on Drugs and Therapeutics | volume = 60 | issue = 1562 | pages = 206–208 | date = December 2018 | pmid = 30625123 }}</ref> Availability worldwide be limited, plus de drug remain marketed only insyd de United States den [[Mexico]].<ref name="pmid18771744" /><ref name=Wal2008>{{cite book | vauthors = Walsh TD, Caraceni AT, Fainsinger R, Foley KM, Glare P, Goh C, Lloyd-Williams M, Olarte JN, Radbruch L |title=Palliative Medicine E-Book |date=2008 |publisher=Elsevier Health Sciences |isbn=9781437721942 |page=751 |url=https://books.google.com/books?id=z0xgDAAAQBAJ&pg=PA751 }}</ref><ref name="SchweizerischerApotheker-Verein2000">{{cite book |author=Schweizerischer Apotheker-Verein |url=https://books.google.com/books?id=5GpcTQD_L2oC&pg=PA109 |title=Index Nominum 2000: International Drug Directory |publisher=Medpharm Scientific Publishers |year=2000 |isbn=978-3-88763-075-1 |page=109 |access-date=12 January 2024}}</ref> Insyd 2023, na e be de 122nd most commonly prescribed medication insyd de United States, plus more tdan 5{{nbsp}}million prescriptions.<ref name="Top 300">{{cite web | title=Top 300 of 2023 | url=https://clincalc.com/DrugStats/Top300Drugs.aspx | website=ClinCalc | access-date=12 August 2025 | archive-date=12 August 2025 | archive-url=https://web.archive.org/web/20250812130026/https://clincalc.com/DrugStats/Top300Drugs.aspx | url-status=live }}</ref><ref name="ClinCalc Benzonatate">{{cite web | title = Benzonatate Drug Usage Statistics, United States, 2014 - 2023 | website = ClinCalc | url = https://clincalc.com/DrugStats/Drugs/Benzonatate | access-date = 18 August 2025 }}</ref> Na a 2023 [[systematic review]] find say der be inadequate evidence to support de effectiveness den safety of benzonatate for cough den highlighted rising safety concerns.<ref name="pmid36688284">{{cite journal | vauthors = Costantino RC, Leonard J, Gorman EF, Ventura D, Baltz A, Gressler LE | title = Benzonatate Safety and Effectiveness: A Systematic Review of the Literature | journal = Annals of Pharmacotherapy | volume = 57 | issue = 10 | pages = 1221–1236 | date = October 2023 | pmid = 36688284 | doi = 10.1177/10600280221135750 | s2cid = 256102939 }}</ref>
== References ==
<references />
== External links ==
[[Category:Translated from MDWiki]]
g67x0sbca0j8yq51otcy00d0kra4mwd
114925
114924
2026-10-16T16:40:26Z
DaSupremo
9
Improve article
114925
wikitext
text/x-wiki
{{Databox}}
'''Benzonatate''' ({{IPAc-en|b|ɛ|n|ˈ|z|oʊ|n|ə|t|eɪ|t}}), dem sell under de brand name '''Tessalon''' among odas, be a medication wey be used for de symptomatic relief of [[cough]].<ref name=AHFS2019>{{cite web |title=Benzonatate Monograph for Professionals |url=https://www.drugs.com/monograph/benzonatate.html |website=Drugs.com |publisher=American Society of Health-System Pharmacists |access-date=23 March 2019 }}</ref><ref name=Bec2010>{{cite journal | vauthors = Becker DE | title = Nausea, vomiting, and hiccups: a review of mechanisms and treatment | journal = Anesthesia Progress | volume = 57 | issue = 4 | pages = 150–6; quiz 157 | date = 2010 | pmid = 21174569 | pmc = 3006663 | doi = 10.2344/0003-3006-57.4.150 }}</ref> Dem dey take benzonatate [[oral administration|by mouth]].<ref name=AHFS2019/><ref name="Homsi20012">{{cite journal |vauthors=Homsi J, Walsh D, Nelson KA |date=November 2001 |title=Important drugs for cough in advanced cancer |journal=Supportive Care in Cancer |volume=9 |issue=8 |pages=565–574 |doi=10.1007/s005200100252 |pmid=11762966 |s2cid=25881426}}</ref> Effects generally dey begin within 20{{nbsp}}minutes den dey last between 3 den 8{{nbsp}}hours.<ref name=AHFS2019/><ref name="Tessalon label2">{{cite web |date=20 November 2019 |title=Tessalon - benzonatate capsule |url=https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8edd07a0-5f5b-9000-bafb-dbf8ff7609d4 |access-date=21 April 2020 |website=DailyMed}}</ref>
[[Side effect]]s dey include sleepiness, [[dizziness]], [[headache]], [[upset stomach]], [[skin rash]], [[hallucination]]s, den allergic reactions.<ref name=AHFS2019/> [[Drug overdose|Overdosage]] fi result in serious [[adverse effect]]s wey dey include [[seizures]], [[irregular heartbeat]], [[cardiac arrest]], den death.<ref name="ML2018">{{cite journal |vauthors= |date=December 2018 |title=Drugs for cough |journal=The Medical Letter on Drugs and Therapeutics |volume=60 |issue=1562 |pages=206–208 |pmid=30625123}}</ref><ref name="pmid34219543" /> Overdose of only a small number of capsules fi be fatal.<ref name="pmid34219543">{{cite journal | vauthors = Minhaj FS, Leonard JB | title = A description of the clinical course of severe benzonatate poisonings reported in the literature and to NPDS: A systematic review supplemented with NPDS cases | journal = Hum Exp Toxicol | volume = 40 | issue = 12_suppl | pages = S39–S48 | date = December 2021 | pmid = 34219543 | doi = 10.1177/09603271211030560 | bibcode = 2021HETox..40S..39M | s2cid = 235735410 | url = }}</ref> Chewing or sucking on the capsule, releasing the drug into the mouth, can also lead to [[laryngospasm]], [[bronchospasm]], and [[circulatory collapse]].<ref name=AHFS2019/> E be unclear if ein use insyd [[pregnancy]] anaa [[breastfeeding]] while on de medication be safe.<ref name=Preg2020>{{cite web|url=https://www.drugs.com/pregnancy/benzonatate.html|title=Benzonatate Use During Pregnancy|date=10 October 2019|website=Drugs.com|access-date=20 February 2020}}</ref> Benzonatate be a [[local anesthetic]] den [[voltage-gated sodium channel]] [[sodium channel blocker|blocker]].<ref>{{Cite web |title=Benzonatate |url=https://go.drugbank.com/drugs/DB00868 |access-date=2026-10-16 |website=go.drugbank.com |language=en}}</ref> E be theorized to work by inhibiting [[pulmonary stretch receptor|stretch receptors insyd de lungs]], in turn dey suppress de [[cough reflex]] insyd de brain.<ref name="AHFS2019" /> Benzonatate be [[structural analog|structurally related]] to oda local anesthetics like [[procaine]] den [[tetracaine]].<ref name=AHFS2019/><ref name="pmid18771744">{{cite journal |vauthors=Dicpinigaitis PV |date=April 2009 |title=Currently available antitussives |url= |journal=Pulm Pharmacol Ther |volume=22 |issue=2 |pages=148–51 |doi=10.1016/j.pupt.2008.08.002 |pmid=18771744}}</ref>
Na dem discover benzonatate insyd 1956 wey na dem approve am for medical use insyd de [[United States]] insyd 1958.<ref name=AHFS2019/><ref name="Homsi2001">{{cite journal |vauthors=Homsi J, Walsh D, Nelson KA |date=November 2001 |title=Important drugs for cough in advanced cancer |journal=Supportive Care in Cancer |volume=9 |issue=8 |pages=565–574 |doi=10.1007/s005200100252 |pmid=11762966 |s2cid=25881426}}</ref> E be available as a [[generic medication]].<ref name=ML2018>{{cite journal | vauthors = | title = Drugs for cough | journal = The Medical Letter on Drugs and Therapeutics | volume = 60 | issue = 1562 | pages = 206–208 | date = December 2018 | pmid = 30625123 }}</ref> Availability worldwide be limited, plus de drug remain marketed only insyd de United States den [[Mexico]].<ref name="pmid18771744" /><ref name=Wal2008>{{cite book | vauthors = Walsh TD, Caraceni AT, Fainsinger R, Foley KM, Glare P, Goh C, Lloyd-Williams M, Olarte JN, Radbruch L |title=Palliative Medicine E-Book |date=2008 |publisher=Elsevier Health Sciences |isbn=9781437721942 |page=751 |url=https://books.google.com/books?id=z0xgDAAAQBAJ&pg=PA751 }}</ref><ref name="SchweizerischerApotheker-Verein2000">{{cite book |author=Schweizerischer Apotheker-Verein |url=https://books.google.com/books?id=5GpcTQD_L2oC&pg=PA109 |title=Index Nominum 2000: International Drug Directory |publisher=Medpharm Scientific Publishers |year=2000 |isbn=978-3-88763-075-1 |page=109 |access-date=12 January 2024}}</ref> Insyd 2023, na e be de 122nd most commonly prescribed medication insyd de United States, plus more tdan 5{{nbsp}}million prescriptions.<ref name="Top 300">{{cite web | title=Top 300 of 2023 | url=https://clincalc.com/DrugStats/Top300Drugs.aspx | website=ClinCalc | access-date=12 August 2025 | archive-date=12 August 2025 | archive-url=https://web.archive.org/web/20250812130026/https://clincalc.com/DrugStats/Top300Drugs.aspx | url-status=live }}</ref><ref name="ClinCalc Benzonatate">{{cite web | title = Benzonatate Drug Usage Statistics, United States, 2014 - 2023 | website = ClinCalc | url = https://clincalc.com/DrugStats/Drugs/Benzonatate | access-date = 18 August 2025 }}</ref> Na a 2023 [[systematic review]] find say der be inadequate evidence to support de effectiveness den safety of benzonatate for cough den highlighted rising safety concerns.<ref name="pmid36688284">{{cite journal | vauthors = Costantino RC, Leonard J, Gorman EF, Ventura D, Baltz A, Gressler LE | title = Benzonatate Safety and Effectiveness: A Systematic Review of the Literature | journal = Annals of Pharmacotherapy | volume = 57 | issue = 10 | pages = 1221–1236 | date = October 2023 | pmid = 36688284 | doi = 10.1177/10600280221135750 | s2cid = 256102939 }}</ref>
== References ==
<references />
== External links ==
{{Commons}}
[[Category:4-Aminobenzoate esters]]
[[Category:Antitussives]]
[[Category:Glycol ethers]]
[[Category:Local anesthetics]]
[[Category:Methoxy compounds]]
[[Category:Secondary amines]]
[[Category:Sodium channel blockers]]
[[Category:Translated from MDWiki]]
ovv0fn7h6007h6zxebotz4tqhj8iutl
Category:4-Aminobenzoate esters
14
31033
114926
2026-10-16T16:41:03Z
DaSupremo
9
Fresh category
114926
wikitext
text/x-wiki
phoiac9h4m842xq45sp7s6u21eteeq1
Pneumothorax
0
31034
114927
2026-10-16T16:54:34Z
DaSupremo
9
Created by translating the page [[:mdwiki:Special:Redirect/revision/1504456|Pneumothorax]] to:gpe #mdwikicx
114927
wikitext
text/x-wiki
[[Category:Translated from MDWiki]]
r0gf7axtnvt68k0p85plnlehx64o08u
114928
114927
2026-10-16T17:21:57Z
DaSupremo
9
Improve article
114928
wikitext
text/x-wiki
{{Databox}}
A '''pneumothorax''' be a collection of air insyd de [[pleural space]] between de [[lung]] den de [[chest wall]].<ref name="BMJ20142">{{cite journal |vauthors=Bintcliffe O, Maskell N |date=May 2014 |title=Spontaneous pneumothorax |journal=BMJ |volume=348 |issue=may08 1 |doi=10.1136/bmj.g2928 |pmid=24812003 |s2cid=32575512 |article-number=g2928}}</ref> Symptoms typically dey include sudden onset of sharp, one-sided [[chest pain]] den [[dyspnea|shortness of breath]].<ref name="NIH2011Sym">{{cite web|title=What Are the Signs and Symptoms of Pleurisy and Other Pleural Disorders|url=http://www.nhlbi.nih.gov/health/health-topics/topics/pleurisy/signs|website=www.nhlbi.nih.gov|access-date=31 October 2016|date=21 September 2011|archive-url=https://web.archive.org/web/20161008061144/https://www.nhlbi.nih.gov/health/health-topics/topics/pleurisy/signs|archive-date=8 October 2016}}</ref> Insyd a minority of cases, a one-way valve be formed by an area of damaged [[Tissue (biology)|tissue]], insyd wich case de air pressure insyd de space between chest wall den lungs fi be higher; dis be historically referred to as a tension pneumothorax, although ein existence among spontaneous episodes be a matter of debate.<ref name="BMJ20142" /><ref>{{cite journal | vauthors = Simpson G, Vincent S, Ferns J | title = Spontaneous tension pneumothorax: what is it and does it exist? | journal = Intern Med J | volume = 42 | issue = 6 | pages = 1157–60 | date = October 2012 | pmid = 23227475 | doi = 10.1111/j.1445-5994.2012.02910.x }}</ref> Dis fi cause a steadily worsening [[Hypoxia (medical)|oxygen shortage]] den [[hypotension|low blood pressure]], wey dey lead to a potentially-fatal [[obstructive shock]] unless dem reverse.<ref name="BMJ20142" /> Very rarely, both lungs fi be affected by a pneumothorax.<ref>{{cite journal | vauthors = Morjaria JB, Lakshminarayana UB, Liu-Shiu-Cheong P, Kastelik JA | title = Pneumothorax: a tale of pain or spontaneity | journal = Therapeutic Advances in Chronic Disease | volume = 5 | issue = 6 | pages = 269–273 | date = November 2014 | pmid = 25364493 | pmc = 4205574 | doi = 10.1177/2040622314551549 }}</ref> E be often called a "'''collapsed lung'''", although dat term sanso fi refer to [[atelectasis]].<ref name="Or2004">{{cite book| vauthors = Orenstein DM |title=Cystic Fibrosis: A Guide for Patient and Family|date=2004|publisher=Lippincott Williams & Wilkins|isbn=978-0-7817-4152-1|page=62|url=https://books.google.com/books?id=BGefk9zBqlgC&pg=PA62|language=en|url-status=live|archive-url=https://web.archive.org/web/20161031212134/https://books.google.ca/books?id=BGefk9zBqlgC&pg=PA62|archive-date=31 October 2016}}</ref>
== References ==
[[Category:Translated from MDWiki]]
<references />
== External links ==
0qgz595m776y5edd08cb4wljqz9rtjg
114929
114928
2026-10-16T17:30:47Z
DaSupremo
9
Improve article
114929
wikitext
text/x-wiki
{{Databox}}
A '''pneumothorax''' be a collection of air insyd de [[pleural space]] between de [[lung]] den de [[chest wall]].<ref name="BMJ20142">{{cite journal |vauthors=Bintcliffe O, Maskell N |date=May 2014 |title=Spontaneous pneumothorax |journal=BMJ |volume=348 |issue=may08 1 |doi=10.1136/bmj.g2928 |pmid=24812003 |s2cid=32575512 |article-number=g2928}}</ref> Symptoms typically dey include sudden onset of sharp, one-sided [[chest pain]] den [[dyspnea|shortness of breath]].<ref name="NIH2011Sym">{{cite web|title=What Are the Signs and Symptoms of Pleurisy and Other Pleural Disorders|url=http://www.nhlbi.nih.gov/health/health-topics/topics/pleurisy/signs|website=www.nhlbi.nih.gov|access-date=31 October 2016|date=21 September 2011|archive-url=https://web.archive.org/web/20161008061144/https://www.nhlbi.nih.gov/health/health-topics/topics/pleurisy/signs|archive-date=8 October 2016}}</ref> Insyd a minority of cases, a one-way valve be formed by an area of damaged [[Tissue (biology)|tissue]], insyd wich case de air pressure insyd de space between chest wall den lungs fi be higher; dis be historically referred to as a tension pneumothorax, although ein existence among spontaneous episodes be a matter of debate.<ref name="BMJ20142" /><ref>{{cite journal | vauthors = Simpson G, Vincent S, Ferns J | title = Spontaneous tension pneumothorax: what is it and does it exist? | journal = Intern Med J | volume = 42 | issue = 6 | pages = 1157–60 | date = October 2012 | pmid = 23227475 | doi = 10.1111/j.1445-5994.2012.02910.x }}</ref> Dis fi cause a steadily worsening [[Hypoxia (medical)|oxygen shortage]] den [[hypotension|low blood pressure]], wey dey lead to a potentially-fatal [[obstructive shock]] unless dem reverse.<ref name="BMJ20142" /> Very rarely, both lungs fi be affected by a pneumothorax.<ref>{{cite journal | vauthors = Morjaria JB, Lakshminarayana UB, Liu-Shiu-Cheong P, Kastelik JA | title = Pneumothorax: a tale of pain or spontaneity | journal = Therapeutic Advances in Chronic Disease | volume = 5 | issue = 6 | pages = 269–273 | date = November 2014 | pmid = 25364493 | pmc = 4205574 | doi = 10.1177/2040622314551549 }}</ref> E be often called a "'''collapsed lung'''", although dat term sanso fi refer to [[atelectasis]].<ref name="Or2004">{{cite book| vauthors = Orenstein DM |title=Cystic Fibrosis: A Guide for Patient and Family|date=2004|publisher=Lippincott Williams & Wilkins|isbn=978-0-7817-4152-1|page=62|url=https://books.google.com/books?id=BGefk9zBqlgC&pg=PA62|language=en|url-status=live|archive-url=https://web.archive.org/web/20161031212134/https://books.google.ca/books?id=BGefk9zBqlgC&pg=PA62|archive-date=31 October 2016}}</ref>
A primary spontaneous pneumothorax be one wey dey occur widout an apparent cause den insyd de absence of significant [[lung disease]].<ref name=BMJ2014/> Ein occurrence be fundamentally a nuisance.<ref>{{cite journal | vauthors = Light RW | title = Management of spontaneous pneumothorax | journal = Am Rev Respir Dis | date = 1993 | volume = 148 | issue = 1 | pages = 245–8 | pmid = 8317808 | doi = 10.1164/ajrccm/148.1.245}}</ref> A secondary spontaneous pneumothorax dey occur insyd de presence of existing lung disease.<ref name="BMJ2014">{{cite journal | vauthors = Bintcliffe O, Maskell N | title = Spontaneous pneumothorax | journal = BMJ | volume = 348 | article-number = g2928 | date = May 2014 | issue = may08 1 | pmid = 24812003 | doi = 10.1136/bmj.g2928 | s2cid = 32575512 }}</ref><ref name="Weinberger">{{cite book | vauthors = Weinberger S, Cockrill B, Mandel J |title=Principles of Pulmonary Medicine |date=2019 |publisher=Elsevier |isbn=978-0-323-52371-4 |pages=215–216 |edition=7th}}</ref> Smoking dey increase de risk of primary spontaneous pneumothorax, while de main underlying causes for secondary pneumothorax be [[COPD]], [[asthma]], den [[tuberculosis]].<ref name=BMJ2014/><ref name=NIH2011Cau>{{cite web|title=What Causes Pleurisy and Other Pleural Disorders?|url=http://www.nhlbi.nih.gov/health/health-topics/topics/pleurisy/causes|website=NHLBI|access-date=31 October 2016|date=21 September 2011|archive-url=https://web.archive.org/web/20161008061131/https://www.nhlbi.nih.gov/health/health-topics/topics/pleurisy/causes|archive-date=8 October 2016}}</ref> A traumatic pneumothorax fi develop from [[physical trauma]] to de [[chest]] (wey dey include a [[blast injury]]) anaa from a [[iatrogenesis|complication of a healthcare intervention]].<ref>{{cite journal | vauthors = Slade M | title = Management of pneumothorax and prolonged air leak | journal = Seminars in Respiratory and Critical Care Medicine | volume = 35 | issue = 6 | pages = 706–714 | date = December 2014 | pmid = 25463161 | doi = 10.1055/s-0034-1395502 | s2cid = 35518356 }}</ref><ref name="Wolf2009">{{cite journal | vauthors = Wolf SJ, Bebarta VS, Bonnett CJ, Pons PT, Cantrill SV | title = Blast injuries | journal = Lancet | volume = 374 | issue = 9687 | pages = 405–415 | date = August 2009 | pmid = 19631372 | doi = 10.1016/S0140-6736(09)60257-9 | s2cid = 13746434 }}</ref>
== References ==
<references />
== External links ==
[[Category:Translated from MDWiki]]
s0hcebawr58d186iwk638r2zgeo31yw
114930
114929
2026-10-16T17:35:33Z
DaSupremo
9
Improve article
114930
wikitext
text/x-wiki
{{Databox}}
A '''pneumothorax''' be a collection of air insyd de [[pleural space]] between de [[lung]] den de [[chest wall]].<ref name="BMJ20142">{{cite journal |vauthors=Bintcliffe O, Maskell N |date=May 2014 |title=Spontaneous pneumothorax |journal=BMJ |volume=348 |issue=may08 1 |doi=10.1136/bmj.g2928 |pmid=24812003 |s2cid=32575512 |article-number=g2928}}</ref> Symptoms typically dey include sudden onset of sharp, one-sided [[chest pain]] den [[dyspnea|shortness of breath]].<ref name="NIH2011Sym">{{cite web|title=What Are the Signs and Symptoms of Pleurisy and Other Pleural Disorders|url=http://www.nhlbi.nih.gov/health/health-topics/topics/pleurisy/signs|website=www.nhlbi.nih.gov|access-date=31 October 2016|date=21 September 2011|archive-url=https://web.archive.org/web/20161008061144/https://www.nhlbi.nih.gov/health/health-topics/topics/pleurisy/signs|archive-date=8 October 2016}}</ref> Insyd a minority of cases, a one-way valve be formed by an area of damaged [[Tissue (biology)|tissue]], insyd wich case de air pressure insyd de space between chest wall den lungs fi be higher; dis be historically referred to as a tension pneumothorax, although ein existence among spontaneous episodes be a matter of debate.<ref name="BMJ20142" /><ref>{{cite journal | vauthors = Simpson G, Vincent S, Ferns J | title = Spontaneous tension pneumothorax: what is it and does it exist? | journal = Intern Med J | volume = 42 | issue = 6 | pages = 1157–60 | date = October 2012 | pmid = 23227475 | doi = 10.1111/j.1445-5994.2012.02910.x }}</ref> Dis fi cause a steadily worsening [[Hypoxia (medical)|oxygen shortage]] den [[hypotension|low blood pressure]], wey dey lead to a potentially-fatal [[obstructive shock]] unless dem reverse.<ref name="BMJ20142" /> Very rarely, both lungs fi be affected by a pneumothorax.<ref>{{cite journal | vauthors = Morjaria JB, Lakshminarayana UB, Liu-Shiu-Cheong P, Kastelik JA | title = Pneumothorax: a tale of pain or spontaneity | journal = Therapeutic Advances in Chronic Disease | volume = 5 | issue = 6 | pages = 269–273 | date = November 2014 | pmid = 25364493 | pmc = 4205574 | doi = 10.1177/2040622314551549 }}</ref> E be often called a "'''collapsed lung'''", although dat term sanso fi refer to [[atelectasis]].<ref name="Or2004">{{cite book| vauthors = Orenstein DM |title=Cystic Fibrosis: A Guide for Patient and Family|date=2004|publisher=Lippincott Williams & Wilkins|isbn=978-0-7817-4152-1|page=62|url=https://books.google.com/books?id=BGefk9zBqlgC&pg=PA62|language=en|url-status=live|archive-url=https://web.archive.org/web/20161031212134/https://books.google.ca/books?id=BGefk9zBqlgC&pg=PA62|archive-date=31 October 2016}}</ref>
A primary spontaneous pneumothorax be one wey dey occur widout an apparent cause den insyd de absence of significant [[lung disease]].<ref name=BMJ2014/> Ein occurrence be fundamentally a nuisance.<ref>{{cite journal | vauthors = Light RW | title = Management of spontaneous pneumothorax | journal = Am Rev Respir Dis | date = 1993 | volume = 148 | issue = 1 | pages = 245–8 | pmid = 8317808 | doi = 10.1164/ajrccm/148.1.245}}</ref> A secondary spontaneous pneumothorax dey occur insyd de presence of existing lung disease.<ref name="BMJ2014">{{cite journal | vauthors = Bintcliffe O, Maskell N | title = Spontaneous pneumothorax | journal = BMJ | volume = 348 | article-number = g2928 | date = May 2014 | issue = may08 1 | pmid = 24812003 | doi = 10.1136/bmj.g2928 | s2cid = 32575512 }}</ref><ref name="Weinberger">{{cite book | vauthors = Weinberger S, Cockrill B, Mandel J |title=Principles of Pulmonary Medicine |date=2019 |publisher=Elsevier |isbn=978-0-323-52371-4 |pages=215–216 |edition=7th}}</ref> Smoking dey increase de risk of primary spontaneous pneumothorax, while de main underlying causes for secondary pneumothorax be [[COPD]], [[asthma]], den [[tuberculosis]].<ref name=BMJ2014/><ref name=NIH2011Cau>{{cite web|title=What Causes Pleurisy and Other Pleural Disorders?|url=http://www.nhlbi.nih.gov/health/health-topics/topics/pleurisy/causes|website=NHLBI|access-date=31 October 2016|date=21 September 2011|archive-url=https://web.archive.org/web/20161008061131/https://www.nhlbi.nih.gov/health/health-topics/topics/pleurisy/causes|archive-date=8 October 2016}}</ref> A traumatic pneumothorax fi develop from [[physical trauma]] to de [[chest]] (wey dey include a [[blast injury]]) anaa from a [[iatrogenesis|complication of a healthcare intervention]].<ref>{{cite journal | vauthors = Slade M | title = Management of pneumothorax and prolonged air leak | journal = Seminars in Respiratory and Critical Care Medicine | volume = 35 | issue = 6 | pages = 706–714 | date = December 2014 | pmid = 25463161 | doi = 10.1055/s-0034-1395502 | s2cid = 35518356 }}</ref><ref name="Wolf2009">{{cite journal | vauthors = Wolf SJ, Bebarta VS, Bonnett CJ, Pons PT, Cantrill SV | title = Blast injuries | journal = Lancet | volume = 374 | issue = 9687 | pages = 405–415 | date = August 2009 | pmid = 19631372 | doi = 10.1016/S0140-6736(09)60257-9 | s2cid = 13746434 }}</ref>
Diagnosis of a pneumothorax by [[physical examination]] alone fi be difficult (particularly insyd smaller pneumothoraces).<ref>{{cite journal | vauthors = Yarmus L, Feller-Kopman D | title = Pneumothorax in the critically ill patient | journal = Chest | volume = 141 | issue = 4 | pages = 1098–1105 | date = April 2012 | pmid = 22474153 | doi = 10.1378/chest.11-1691 | s2cid = 207386345 }}</ref> A [[chest radiograph|chest X-ray]], [[X-ray computed tomography|computed tomography]] (CT) scan, anaa [[ultrasound]] usually be used to confirm ein presence.<ref name="Chen2015">{{cite journal | vauthors = Chen L, Zhang Z | title = Bedside ultrasonography for diagnosis of pneumothorax | journal = Quantitative Imaging in Medicine and Surgery | volume = 5 | issue = 4 | pages = 618–623 | date = August 2015 | pmid = 26435925 | pmc = 4559988 | doi = 10.3978/j.issn.2223-4292.2015.05.04 }}</ref> Oda conditions wey fi result in similar symptoms dey include a [[hemothorax]] (buildup of [[blood]] insyd de pleural space), [[pulmonary embolism]], den [[myocardial infarction|heart attack]].<ref name=NIH2011Sym/><ref>{{cite book| vauthors = Peters JR, Egan D, Mick NW | veditors = Nadel ES |title=Blueprints Emergency Medicine|date=2006|publisher=Lippincott Williams & Wilkins|isbn=978-1-4051-0461-6|page=44|url=https://books.google.com/books?id=NvqaWHi1OTsC&pg=PA44|language=en|url-status=live|archive-url=https://web.archive.org/web/20161101041122/https://books.google.ca/books?id=NvqaWHi1OTsC&pg=PA44|archive-date=1 November 2016}}</ref> A large [[Chronic obstructive pulmonary disease#Pathophysiology|bulla]] fi look similar on a chest X-ray.<ref name=BMJ2014/>
== References ==
<references />
== External links ==
[[Category:Translated from MDWiki]]
2foxehb80k2k5yhz0dfe6eqw4wibqfm
114931
114930
2026-10-16T17:41:39Z
DaSupremo
9
Improve article
114931
wikitext
text/x-wiki
{{Databox}}
A '''pneumothorax''' be a collection of air insyd de [[pleural space]] between de [[lung]] den de [[chest wall]].<ref name="BMJ20142">{{cite journal |vauthors=Bintcliffe O, Maskell N |date=May 2014 |title=Spontaneous pneumothorax |journal=BMJ |volume=348 |issue=may08 1 |doi=10.1136/bmj.g2928 |pmid=24812003 |s2cid=32575512 |article-number=g2928}}</ref> Symptoms typically dey include sudden onset of sharp, one-sided [[chest pain]] den [[dyspnea|shortness of breath]].<ref name="NIH2011Sym">{{cite web|title=What Are the Signs and Symptoms of Pleurisy and Other Pleural Disorders|url=http://www.nhlbi.nih.gov/health/health-topics/topics/pleurisy/signs|website=www.nhlbi.nih.gov|access-date=31 October 2016|date=21 September 2011|archive-url=https://web.archive.org/web/20161008061144/https://www.nhlbi.nih.gov/health/health-topics/topics/pleurisy/signs|archive-date=8 October 2016}}</ref> Insyd a minority of cases, a one-way valve be formed by an area of damaged [[Tissue (biology)|tissue]], insyd wich case de air pressure insyd de space between chest wall den lungs fi be higher; dis be historically referred to as a tension pneumothorax, although ein existence among spontaneous episodes be a matter of debate.<ref name="BMJ20142" /><ref>{{cite journal | vauthors = Simpson G, Vincent S, Ferns J | title = Spontaneous tension pneumothorax: what is it and does it exist? | journal = Intern Med J | volume = 42 | issue = 6 | pages = 1157–60 | date = October 2012 | pmid = 23227475 | doi = 10.1111/j.1445-5994.2012.02910.x }}</ref> Dis fi cause a steadily worsening [[Hypoxia (medical)|oxygen shortage]] den [[hypotension|low blood pressure]], wey dey lead to a potentially-fatal [[obstructive shock]] unless dem reverse.<ref name="BMJ20142" /> Very rarely, both lungs fi be affected by a pneumothorax.<ref>{{cite journal | vauthors = Morjaria JB, Lakshminarayana UB, Liu-Shiu-Cheong P, Kastelik JA | title = Pneumothorax: a tale of pain or spontaneity | journal = Therapeutic Advances in Chronic Disease | volume = 5 | issue = 6 | pages = 269–273 | date = November 2014 | pmid = 25364493 | pmc = 4205574 | doi = 10.1177/2040622314551549 }}</ref> E be often called a "'''collapsed lung'''", although dat term sanso fi refer to [[atelectasis]].<ref name="Or2004">{{cite book| vauthors = Orenstein DM |title=Cystic Fibrosis: A Guide for Patient and Family|date=2004|publisher=Lippincott Williams & Wilkins|isbn=978-0-7817-4152-1|page=62|url=https://books.google.com/books?id=BGefk9zBqlgC&pg=PA62|language=en|url-status=live|archive-url=https://web.archive.org/web/20161031212134/https://books.google.ca/books?id=BGefk9zBqlgC&pg=PA62|archive-date=31 October 2016}}</ref>
A primary spontaneous pneumothorax be one wey dey occur widout an apparent cause den insyd de absence of significant [[lung disease]].<ref name=BMJ2014/> Ein occurrence be fundamentally a nuisance.<ref>{{cite journal | vauthors = Light RW | title = Management of spontaneous pneumothorax | journal = Am Rev Respir Dis | date = 1993 | volume = 148 | issue = 1 | pages = 245–8 | pmid = 8317808 | doi = 10.1164/ajrccm/148.1.245}}</ref> A secondary spontaneous pneumothorax dey occur insyd de presence of existing lung disease.<ref name="BMJ2014">{{cite journal | vauthors = Bintcliffe O, Maskell N | title = Spontaneous pneumothorax | journal = BMJ | volume = 348 | article-number = g2928 | date = May 2014 | issue = may08 1 | pmid = 24812003 | doi = 10.1136/bmj.g2928 | s2cid = 32575512 }}</ref><ref name="Weinberger">{{cite book | vauthors = Weinberger S, Cockrill B, Mandel J |title=Principles of Pulmonary Medicine |date=2019 |publisher=Elsevier |isbn=978-0-323-52371-4 |pages=215–216 |edition=7th}}</ref> Smoking dey increase de risk of primary spontaneous pneumothorax, while de main underlying causes for secondary pneumothorax be [[COPD]], [[asthma]], den [[tuberculosis]].<ref name=BMJ2014/><ref name=NIH2011Cau>{{cite web|title=What Causes Pleurisy and Other Pleural Disorders?|url=http://www.nhlbi.nih.gov/health/health-topics/topics/pleurisy/causes|website=NHLBI|access-date=31 October 2016|date=21 September 2011|archive-url=https://web.archive.org/web/20161008061131/https://www.nhlbi.nih.gov/health/health-topics/topics/pleurisy/causes|archive-date=8 October 2016}}</ref> A traumatic pneumothorax fi develop from [[physical trauma]] to de [[chest]] (wey dey include a [[blast injury]]) anaa from a [[iatrogenesis|complication of a healthcare intervention]].<ref>{{cite journal | vauthors = Slade M | title = Management of pneumothorax and prolonged air leak | journal = Seminars in Respiratory and Critical Care Medicine | volume = 35 | issue = 6 | pages = 706–714 | date = December 2014 | pmid = 25463161 | doi = 10.1055/s-0034-1395502 | s2cid = 35518356 }}</ref><ref name="Wolf2009">{{cite journal | vauthors = Wolf SJ, Bebarta VS, Bonnett CJ, Pons PT, Cantrill SV | title = Blast injuries | journal = Lancet | volume = 374 | issue = 9687 | pages = 405–415 | date = August 2009 | pmid = 19631372 | doi = 10.1016/S0140-6736(09)60257-9 | s2cid = 13746434 }}</ref>
Diagnosis of a pneumothorax by [[physical examination]] alone fi be difficult (particularly insyd smaller pneumothoraces).<ref>{{cite journal | vauthors = Yarmus L, Feller-Kopman D | title = Pneumothorax in the critically ill patient | journal = Chest | volume = 141 | issue = 4 | pages = 1098–1105 | date = April 2012 | pmid = 22474153 | doi = 10.1378/chest.11-1691 | s2cid = 207386345 }}</ref> A [[chest radiograph|chest X-ray]], [[X-ray computed tomography|computed tomography]] (CT) scan, anaa [[ultrasound]] usually be used to confirm ein presence.<ref name="Chen2015">{{cite journal | vauthors = Chen L, Zhang Z | title = Bedside ultrasonography for diagnosis of pneumothorax | journal = Quantitative Imaging in Medicine and Surgery | volume = 5 | issue = 4 | pages = 618–623 | date = August 2015 | pmid = 26435925 | pmc = 4559988 | doi = 10.3978/j.issn.2223-4292.2015.05.04 }}</ref> Oda conditions wey fi result in similar symptoms dey include a [[hemothorax]] (buildup of [[blood]] insyd de pleural space), [[pulmonary embolism]], den [[myocardial infarction|heart attack]].<ref name=NIH2011Sym/><ref>{{cite book| vauthors = Peters JR, Egan D, Mick NW | veditors = Nadel ES |title=Blueprints Emergency Medicine|date=2006|publisher=Lippincott Williams & Wilkins|isbn=978-1-4051-0461-6|page=44|url=https://books.google.com/books?id=NvqaWHi1OTsC&pg=PA44|language=en|url-status=live|archive-url=https://web.archive.org/web/20161101041122/https://books.google.ca/books?id=NvqaWHi1OTsC&pg=PA44|archive-date=1 November 2016}}</ref> A large [[Chronic obstructive pulmonary disease#Pathophysiology|bulla]] fi look similar on a chest X-ray.<ref name=BMJ2014/>
A small spontaneous pneumothorax go typically resolve widout treatment den dey require only monitoring.<ref name=BMJ2014/> Dis approach fi be most appropriate insyd people wey no get underlying lung disease.<ref name=BMJ2014/> Insyd a larger pneumothorax, anaa if der be shortness of breath, de air fi be removed plus a [[syringe]] anaa a [[chest tube]] connected to a one-way valve system.<ref name=BMJ2014/> Occasionally, [[surgery]] fi be required if tube drainage be unsuccessful, anaa as a preventive measure, if der be repeated episodes.<ref name=BMJ2014/> De surgical treatments usually dey involve [[pleurodesis]] (insyd wich de layers of [[pleura]] be induced to stick togeda) anaa [[pleurectomy]] (de surgical removal of pleural membranes).<ref name=BMJ2014/> Conservative management of primary spontaneous pneumothorax be noninferior to interventional management, plus a lower risk of serious adverse events.<ref> {{ cite journal | vauthors = Brown SG, Ball EL, Perrin K, Asha SE, etal | title = Conservative versus Interventional Treatment for Spontaneous Pneumothorax | journal = N Engl J Med | date = 2020 | volume = 382 | issue = 5 | pages = 405–415 | pmid = 31995686 | doi = 10.1056/NEJMoa1910775 }}</ref> About 17–23 cases of pneumothorax dey occur per 100,000 people per year.<ref name=BMJ2014/><ref name=Chen2015/> Dem be more common insyd men dan women.<ref name=BMJ2014/>
== References ==
<references />
== External links ==
[[Category:Translated from MDWiki]]
liefed6u4734aqrieltpa7vozukeozu
114932
114931
2026-10-16T17:47:38Z
DaSupremo
9
Improve article
114932
wikitext
text/x-wiki
{{Databox}}
A '''pneumothorax''' be a collection of air insyd de [[pleural space]] between de [[lung]] den de [[chest wall]].<ref name="BMJ20142">{{cite journal |vauthors=Bintcliffe O, Maskell N |date=May 2014 |title=Spontaneous pneumothorax |journal=BMJ |volume=348 |issue=may08 1 |doi=10.1136/bmj.g2928 |pmid=24812003 |s2cid=32575512 |article-number=g2928}}</ref> Symptoms typically dey include sudden onset of sharp, one-sided [[chest pain]] den [[dyspnea|shortness of breath]].<ref name="NIH2011Sym">{{cite web|title=What Are the Signs and Symptoms of Pleurisy and Other Pleural Disorders|url=http://www.nhlbi.nih.gov/health/health-topics/topics/pleurisy/signs|website=www.nhlbi.nih.gov|access-date=31 October 2016|date=21 September 2011|archive-url=https://web.archive.org/web/20161008061144/https://www.nhlbi.nih.gov/health/health-topics/topics/pleurisy/signs|archive-date=8 October 2016}}</ref> Insyd a minority of cases, a one-way valve be formed by an area of damaged [[Tissue (biology)|tissue]], insyd wich case de air pressure insyd de space between chest wall den lungs fi be higher; dis be historically referred to as a tension pneumothorax, although ein existence among spontaneous episodes be a matter of debate.<ref name="BMJ20142" /><ref>{{cite journal | vauthors = Simpson G, Vincent S, Ferns J | title = Spontaneous tension pneumothorax: what is it and does it exist? | journal = Intern Med J | volume = 42 | issue = 6 | pages = 1157–60 | date = October 2012 | pmid = 23227475 | doi = 10.1111/j.1445-5994.2012.02910.x }}</ref> Dis fi cause a steadily worsening [[Hypoxia (medical)|oxygen shortage]] den [[hypotension|low blood pressure]], wey dey lead to a potentially-fatal [[obstructive shock]] unless dem reverse.<ref name="BMJ20142" /> Very rarely, both lungs fi be affected by a pneumothorax.<ref>{{cite journal | vauthors = Morjaria JB, Lakshminarayana UB, Liu-Shiu-Cheong P, Kastelik JA | title = Pneumothorax: a tale of pain or spontaneity | journal = Therapeutic Advances in Chronic Disease | volume = 5 | issue = 6 | pages = 269–273 | date = November 2014 | pmid = 25364493 | pmc = 4205574 | doi = 10.1177/2040622314551549 }}</ref> E be often called a "'''collapsed lung'''", although dat term sanso fi refer to [[atelectasis]].<ref name="Or2004">{{cite book| vauthors = Orenstein DM |title=Cystic Fibrosis: A Guide for Patient and Family|date=2004|publisher=Lippincott Williams & Wilkins|isbn=978-0-7817-4152-1|page=62|url=https://books.google.com/books?id=BGefk9zBqlgC&pg=PA62|language=en|url-status=live|archive-url=https://web.archive.org/web/20161031212134/https://books.google.ca/books?id=BGefk9zBqlgC&pg=PA62|archive-date=31 October 2016}}</ref>
A primary spontaneous pneumothorax be one wey dey occur widout an apparent cause den insyd de absence of significant [[lung disease]].<ref name=BMJ2014/> Ein occurrence be fundamentally a nuisance.<ref>{{cite journal | vauthors = Light RW | title = Management of spontaneous pneumothorax | journal = Am Rev Respir Dis | date = 1993 | volume = 148 | issue = 1 | pages = 245–8 | pmid = 8317808 | doi = 10.1164/ajrccm/148.1.245}}</ref> A secondary spontaneous pneumothorax dey occur insyd de presence of existing lung disease.<ref name="BMJ2014">{{cite journal | vauthors = Bintcliffe O, Maskell N | title = Spontaneous pneumothorax | journal = BMJ | volume = 348 | article-number = g2928 | date = May 2014 | issue = may08 1 | pmid = 24812003 | doi = 10.1136/bmj.g2928 | s2cid = 32575512 }}</ref><ref name="Weinberger">{{cite book | vauthors = Weinberger S, Cockrill B, Mandel J |title=Principles of Pulmonary Medicine |date=2019 |publisher=Elsevier |isbn=978-0-323-52371-4 |pages=215–216 |edition=7th}}</ref> Smoking dey increase de risk of primary spontaneous pneumothorax, while de main underlying causes for secondary pneumothorax be [[COPD]], [[asthma]], den [[tuberculosis]].<ref name=BMJ2014/><ref name=NIH2011Cau>{{cite web|title=What Causes Pleurisy and Other Pleural Disorders?|url=http://www.nhlbi.nih.gov/health/health-topics/topics/pleurisy/causes|website=NHLBI|access-date=31 October 2016|date=21 September 2011|archive-url=https://web.archive.org/web/20161008061131/https://www.nhlbi.nih.gov/health/health-topics/topics/pleurisy/causes|archive-date=8 October 2016}}</ref> A traumatic pneumothorax fi develop from [[physical trauma]] to de [[chest]] (wey dey include a [[blast injury]]) anaa from a [[iatrogenesis|complication of a healthcare intervention]].<ref>{{cite journal | vauthors = Slade M | title = Management of pneumothorax and prolonged air leak | journal = Seminars in Respiratory and Critical Care Medicine | volume = 35 | issue = 6 | pages = 706–714 | date = December 2014 | pmid = 25463161 | doi = 10.1055/s-0034-1395502 | s2cid = 35518356 }}</ref><ref name="Wolf2009">{{cite journal | vauthors = Wolf SJ, Bebarta VS, Bonnett CJ, Pons PT, Cantrill SV | title = Blast injuries | journal = Lancet | volume = 374 | issue = 9687 | pages = 405–415 | date = August 2009 | pmid = 19631372 | doi = 10.1016/S0140-6736(09)60257-9 | s2cid = 13746434 }}</ref>
Diagnosis of a pneumothorax by [[physical examination]] alone fi be difficult (particularly insyd smaller pneumothoraces).<ref>{{cite journal | vauthors = Yarmus L, Feller-Kopman D | title = Pneumothorax in the critically ill patient | journal = Chest | volume = 141 | issue = 4 | pages = 1098–1105 | date = April 2012 | pmid = 22474153 | doi = 10.1378/chest.11-1691 | s2cid = 207386345 }}</ref> A [[chest radiograph|chest X-ray]], [[X-ray computed tomography|computed tomography]] (CT) scan, anaa [[ultrasound]] usually be used to confirm ein presence.<ref name="Chen2015">{{cite journal | vauthors = Chen L, Zhang Z | title = Bedside ultrasonography for diagnosis of pneumothorax | journal = Quantitative Imaging in Medicine and Surgery | volume = 5 | issue = 4 | pages = 618–623 | date = August 2015 | pmid = 26435925 | pmc = 4559988 | doi = 10.3978/j.issn.2223-4292.2015.05.04 }}</ref> Oda conditions wey fi result in similar symptoms dey include a [[hemothorax]] (buildup of [[blood]] insyd de pleural space), [[pulmonary embolism]], den [[myocardial infarction|heart attack]].<ref name=NIH2011Sym/><ref>{{cite book| vauthors = Peters JR, Egan D, Mick NW | veditors = Nadel ES |title=Blueprints Emergency Medicine|date=2006|publisher=Lippincott Williams & Wilkins|isbn=978-1-4051-0461-6|page=44|url=https://books.google.com/books?id=NvqaWHi1OTsC&pg=PA44|language=en|url-status=live|archive-url=https://web.archive.org/web/20161101041122/https://books.google.ca/books?id=NvqaWHi1OTsC&pg=PA44|archive-date=1 November 2016}}</ref> A large [[Chronic obstructive pulmonary disease#Pathophysiology|bulla]] fi look similar on a chest X-ray.<ref name=BMJ2014/>
A small spontaneous pneumothorax go typically resolve widout treatment den dey require only monitoring.<ref name=BMJ2014/> Dis approach fi be most appropriate insyd people wey no get underlying lung disease.<ref name=BMJ2014/> Insyd a larger pneumothorax, anaa if der be shortness of breath, de air fi be removed plus a [[syringe]] anaa a [[chest tube]] connected to a one-way valve system.<ref name=BMJ2014/> Occasionally, [[surgery]] fi be required if tube drainage be unsuccessful, anaa as a preventive measure, if der be repeated episodes.<ref name=BMJ2014/> De surgical treatments usually dey involve [[pleurodesis]] (insyd wich de layers of [[pleura]] be induced to stick togeda) anaa [[pleurectomy]] (de surgical removal of pleural membranes).<ref name=BMJ2014/> Conservative management of primary spontaneous pneumothorax be noninferior to interventional management, plus a lower risk of serious adverse events.<ref> {{ cite journal | vauthors = Brown SG, Ball EL, Perrin K, Asha SE, etal | title = Conservative versus Interventional Treatment for Spontaneous Pneumothorax | journal = N Engl J Med | date = 2020 | volume = 382 | issue = 5 | pages = 405–415 | pmid = 31995686 | doi = 10.1056/NEJMoa1910775 }}</ref> About 17–23 cases of pneumothorax dey occur per 100,000 people per year.<ref name=BMJ2014/><ref name=Chen2015/> Dem be more common insyd men dan women.<ref name=BMJ2014/>
== References ==
<references />
== External links ==
{{Commons}}
{{Authority control}}
[[Category:Chest trauma]]
[[Category:Disorders of fascia]]
[[Category:Medical emergencies]]
[[Category:Translated from MDWiki]]
0ggiku073gbdsloqh9n2wba2hh7a1ar
Category:Chest trauma
14
31035
114933
2026-10-16T17:48:02Z
DaSupremo
9
Fresh category
114933
wikitext
text/x-wiki
phoiac9h4m842xq45sp7s6u21eteeq1
Adenosine
0
31036
114934
2026-10-16T18:28:27Z
DaSupremo
9
Created by translating the page [[:mdwiki:Special:Redirect/revision/1500178|Adenosine]] to:gpe #mdwikicx
114934
wikitext
text/x-wiki
[[Category:Translated from MDWiki]]
r0gf7axtnvt68k0p85plnlehx64o08u
114935
114934
2026-10-16T18:33:54Z
DaSupremo
9
Improve article
114935
wikitext
text/x-wiki
{{Databox}}
'''Adenosine''' be a [[endogeny (biology)|chemical dem find insyd mammals]] wich sanso be used as a medication.<ref name=AP2014>{{cite book |title=Adenosine Receptors in Neurology and Psychiatry |publisher=Academic Press |isbn=978-0-12-801318-2 |page=XV |year=2014 |url=https://books.google.ca/books?id=pgZ0AwAAQBAJ&pg=PR15 |language=en |access-date=2020-09-28 |archive-date=2021-08-27 |archive-url=https://web.archive.org/web/20210827205455/https://books.google.ca/books?id=pgZ0AwAAQBAJ&pg=PR15 |url-status=live }} {{Webarchive|url=https://web.archive.org/web/20221014135440/https://books.google.ca/books?id=pgZ0AwAAQBAJ&pg=PR15 |date=2022-10-14 }}</ref><ref name=Taylor2000>{{cite book|title=Index Nominum 2000: International Drug Directory|url=https://books.google.com/books?id=5GpcTQD_L2oC&pg=PA18|date=2000|publisher=Taylor & Francis|isbn=978-3-88763-075-1|pages=18–|access-date=2016-01-05|archive-date=2016-05-04|archive-url=https://web.archive.org/web/20160504043944/https://books.google.com/books?id=5GpcTQD_L2oC&pg=PA18|url-status=live}}</ref> As a medication e be used to treat anaa diagnosis certain forms of [[supraventricular tachycardia]] wey no dey improve plus [[vagal maneuver]]s.<ref name=AHFS2020>{{cite web|title=Adenosine|url=https://www.drugs.com/monograph/adenosine.html|publisher=The American Society of Health-System Pharmacists|access-date=Sep 27, 2020|archive-date=December 23, 2014|archive-url=https://web.archive.org/web/20141223143734/http://www.drugs.com/monograph/adenosine.html|url-status=live}} {{Webarchive|url=https://web.archive.org/web/20141223143734/http://www.drugs.com/monograph/adenosine.html |date=December 23, 2014 }}</ref> E generally be used by rapid injection into a vein.<ref name=AHFS2020/> Onset of action be within 40 seconds den effects dey last for less dan 2 minutes.<ref name=Ae2015>{{cite book |last1=Aehlert |first1=Barbara J. |title=ECGs Made Easy - E-Book |publisher=Elsevier Health Sciences |isbn=978-0-323-39150-4 |url=https://www.google.ca/books/edition/ECGs_Made_Easy_E_Book/jg9qBgAAQBAJ?hl=en&gbpv=1&dq=adenosine+onset+of+action&pg=PA116 |page=116 |year=2015 |access-date=29 September 2020 |language=en |archive-date=27 August 2021 |archive-url=https://web.archive.org/web/20210827205456/https://www.google.ca/books/edition/ECGs_Made_Easy_E_Book/jg9qBgAAQBAJ?hl=en&gbpv=1&dq=adenosine+onset+of+action&pg=PA116 |url-status=live }} {{Webarchive|url=https://web.archive.org/web/20210827205456/https://www.google.ca/books/edition/ECGs_Made_Easy_E_Book/jg9qBgAAQBAJ?hl=en&gbpv=1&dq=adenosine+onset+of+action&pg=PA116 |date=27 August 2021 }}</ref>
== References ==
[[Category:Translated from MDWiki]]
<references />
== External links ==
6yb8z2zsyui1xk4rcqi7ls022f897c3
114936
114935
2026-10-16T18:35:58Z
DaSupremo
9
Improve article
114936
wikitext
text/x-wiki
{{Databox}}
'''Adenosine''' be a [[endogeny (biology)|chemical dem find insyd mammals]] wich sanso be used as a medication.<ref name=AP2014>{{cite book |title=Adenosine Receptors in Neurology and Psychiatry |publisher=Academic Press |isbn=978-0-12-801318-2 |page=XV |year=2014 |url=https://books.google.ca/books?id=pgZ0AwAAQBAJ&pg=PR15 |language=en |access-date=2020-09-28 |archive-date=2021-08-27 |archive-url=https://web.archive.org/web/20210827205455/https://books.google.ca/books?id=pgZ0AwAAQBAJ&pg=PR15 |url-status=live }} {{Webarchive|url=https://web.archive.org/web/20221014135440/https://books.google.ca/books?id=pgZ0AwAAQBAJ&pg=PR15 |date=2022-10-14 }}</ref><ref name=Taylor2000>{{cite book|title=Index Nominum 2000: International Drug Directory|url=https://books.google.com/books?id=5GpcTQD_L2oC&pg=PA18|date=2000|publisher=Taylor & Francis|isbn=978-3-88763-075-1|pages=18–|access-date=2016-01-05|archive-date=2016-05-04|archive-url=https://web.archive.org/web/20160504043944/https://books.google.com/books?id=5GpcTQD_L2oC&pg=PA18|url-status=live}}</ref> As a medication e be used to treat anaa diagnosis certain forms of [[supraventricular tachycardia]] wey no dey improve plus [[vagal maneuver]]s.<ref name=AHFS2020>{{cite web|title=Adenosine|url=https://www.drugs.com/monograph/adenosine.html|publisher=The American Society of Health-System Pharmacists|access-date=Sep 27, 2020|archive-date=December 23, 2014|archive-url=https://web.archive.org/web/20141223143734/http://www.drugs.com/monograph/adenosine.html|url-status=live}} {{Webarchive|url=https://web.archive.org/web/20141223143734/http://www.drugs.com/monograph/adenosine.html |date=December 23, 2014 }}</ref> E generally be used by rapid injection into a vein.<ref name=AHFS2020/> Onset of action be within 40 seconds den effects dey last for less dan 2 minutes.<ref name=Ae2015>{{cite book |last1=Aehlert |first1=Barbara J. |title=ECGs Made Easy - E-Book |publisher=Elsevier Health Sciences |isbn=978-0-323-39150-4 |url=https://www.google.ca/books/edition/ECGs_Made_Easy_E_Book/jg9qBgAAQBAJ?hl=en&gbpv=1&dq=adenosine+onset+of+action&pg=PA116 |page=116 |year=2015 |access-date=29 September 2020 |language=en |archive-date=27 August 2021 |archive-url=https://web.archive.org/web/20210827205456/https://www.google.ca/books/edition/ECGs_Made_Easy_E_Book/jg9qBgAAQBAJ?hl=en&gbpv=1&dq=adenosine+onset+of+action&pg=PA116 |url-status=live }} {{Webarchive|url=https://web.archive.org/web/20210827205456/https://www.google.ca/books/edition/ECGs_Made_Easy_E_Book/jg9qBgAAQBAJ?hl=en&gbpv=1&dq=adenosine+onset+of+action&pg=PA116 |date=27 August 2021 }}</ref>
Common side effects dey include chest pain, feeling faint, shortness of breath, den [[Hypoesthesia|tingling of de skin]].<ref name=AHFS2020/> Serious side effects dey include a worsening [[Arrhythmia|dysrhythmia]] den [[hypotension|low blood pressure]].<ref name=AHFS2020/> While e fi be used during [[pregnancy]], safety no be entirely clear.<ref name=Preg2020>{{cite web |title=Adenosine Use During Pregnancy |url=https://www.drugs.com/pregnancy/adenosine.html |website=Drugs.com |access-date=28 September 2020 |language=en |archive-date=5 December 2020 |archive-url=https://web.archive.org/web/20201205062314/https://www.drugs.com/pregnancy/adenosine.html |url-status=live }} {{Webarchive|url=https://web.archive.org/web/20201205062314/https://www.drugs.com/pregnancy/adenosine.html |date=5 December 2020 }}</ref> Adenosine be one of four [[nucleoside]] building blocks to [[RNA]].<ref name=AP2014/> E dey work by decreasing de frequency by wich electrical signals fi go thru de [[Atrioventricular node|AV node]] of de heart.<ref name=AHFS2020/>
== References ==
<references />
== External links ==
[[Category:Translated from MDWiki]]
7ahidque3m07c6lsut6zpzu9hrpd8a3
114937
114936
2026-10-16T18:39:30Z
DaSupremo
9
Improve article
114937
wikitext
text/x-wiki
{{Databox}}
'''Adenosine''' be a [[endogeny (biology)|chemical dem find insyd mammals]] wich sanso be used as a medication.<ref name=AP2014>{{cite book |title=Adenosine Receptors in Neurology and Psychiatry |publisher=Academic Press |isbn=978-0-12-801318-2 |page=XV |year=2014 |url=https://books.google.ca/books?id=pgZ0AwAAQBAJ&pg=PR15 |language=en |access-date=2020-09-28 |archive-date=2021-08-27 |archive-url=https://web.archive.org/web/20210827205455/https://books.google.ca/books?id=pgZ0AwAAQBAJ&pg=PR15 |url-status=live }} {{Webarchive|url=https://web.archive.org/web/20221014135440/https://books.google.ca/books?id=pgZ0AwAAQBAJ&pg=PR15 |date=2022-10-14 }}</ref><ref name=Taylor2000>{{cite book|title=Index Nominum 2000: International Drug Directory|url=https://books.google.com/books?id=5GpcTQD_L2oC&pg=PA18|date=2000|publisher=Taylor & Francis|isbn=978-3-88763-075-1|pages=18–|access-date=2016-01-05|archive-date=2016-05-04|archive-url=https://web.archive.org/web/20160504043944/https://books.google.com/books?id=5GpcTQD_L2oC&pg=PA18|url-status=live}}</ref> As a medication e be used to treat anaa diagnosis certain forms of [[supraventricular tachycardia]] wey no dey improve plus [[vagal maneuver]]s.<ref name=AHFS2020>{{cite web|title=Adenosine|url=https://www.drugs.com/monograph/adenosine.html|publisher=The American Society of Health-System Pharmacists|access-date=Sep 27, 2020|archive-date=December 23, 2014|archive-url=https://web.archive.org/web/20141223143734/http://www.drugs.com/monograph/adenosine.html|url-status=live}} {{Webarchive|url=https://web.archive.org/web/20141223143734/http://www.drugs.com/monograph/adenosine.html |date=December 23, 2014 }}</ref> E generally be used by rapid injection into a vein.<ref name=AHFS2020/> Onset of action be within 40 seconds den effects dey last for less dan 2 minutes.<ref name=Ae2015>{{cite book |last1=Aehlert |first1=Barbara J. |title=ECGs Made Easy - E-Book |publisher=Elsevier Health Sciences |isbn=978-0-323-39150-4 |url=https://www.google.ca/books/edition/ECGs_Made_Easy_E_Book/jg9qBgAAQBAJ?hl=en&gbpv=1&dq=adenosine+onset+of+action&pg=PA116 |page=116 |year=2015 |access-date=29 September 2020 |language=en |archive-date=27 August 2021 |archive-url=https://web.archive.org/web/20210827205456/https://www.google.ca/books/edition/ECGs_Made_Easy_E_Book/jg9qBgAAQBAJ?hl=en&gbpv=1&dq=adenosine+onset+of+action&pg=PA116 |url-status=live }} {{Webarchive|url=https://web.archive.org/web/20210827205456/https://www.google.ca/books/edition/ECGs_Made_Easy_E_Book/jg9qBgAAQBAJ?hl=en&gbpv=1&dq=adenosine+onset+of+action&pg=PA116 |date=27 August 2021 }}</ref>
Common side effects dey include chest pain, feeling faint, shortness of breath, den [[Hypoesthesia|tingling of de skin]].<ref name=AHFS2020/> Serious side effects dey include a worsening [[Arrhythmia|dysrhythmia]] den [[hypotension|low blood pressure]].<ref name=AHFS2020/> While e fi be used during [[pregnancy]], safety no be entirely clear.<ref name=Preg2020>{{cite web |title=Adenosine Use During Pregnancy |url=https://www.drugs.com/pregnancy/adenosine.html |website=Drugs.com |access-date=28 September 2020 |language=en |archive-date=5 December 2020 |archive-url=https://web.archive.org/web/20201205062314/https://www.drugs.com/pregnancy/adenosine.html |url-status=live }} {{Webarchive|url=https://web.archive.org/web/20201205062314/https://www.drugs.com/pregnancy/adenosine.html |date=5 December 2020 }}</ref> Adenosine be one of four [[nucleoside]] building blocks to [[RNA]].<ref name=AP2014/> E dey work by decreasing de frequency by wich electrical signals fi go thru de [[Atrioventricular node|AV node]] of de heart.<ref name=AHFS2020/>
Adenosine be approved for medical use insyd de [[United States]] insyd 1989.<ref name=AHFS2020/> E; however, be studied within living systems since de 1920s.<ref name=AP2014/> Adenosine be available as a [[generic medication]].<ref name=BNF79>{{cite book |title=BNF 79 |date=March 2020 |publisher=Pharmaceutical Press |location=London |isbn=978-0857113658 |page=110}}</ref> It is not expensive.<ref name=Hitch2019>{{Cite book|last=Hitchings|first=Andrew|url=https://books.google.com/books?id=FPx0DwAAQBAJ|title=The Top 100 Drugs: Clinical Pharmacology and Practical Prescribing|last2=Lonsdale|first2=Dagan|last3=Burrage|first3=Daniel|last4=Baker|first4=Emma|date=2019|publisher=Elsevier|isbn=978-0-7020-7442-4|edition=2nd|pages=34-35|language=en|access-date=2021-11-09|archive-date=2021-05-22|archive-url=https://web.archive.org/web/20210522175005/https://books.google.com/books?id=FPx0DwAAQBAJ|url-status=live}}</ref> Insyd de [[United Kingdom]] insyd 2020 a 6 mg dose costs de NHS about a pound.<ref name=BNF79/>
== References ==
<references />
== External links ==
[[Category:Translated from MDWiki]]
ejqhg385ladxh1gib4e7wp7yp4uju7h
114938
114937
2026-10-16T18:42:58Z
DaSupremo
9
Improve article
114938
wikitext
text/x-wiki
{{Databox}}
'''Adenosine''' be a [[endogeny (biology)|chemical dem find insyd mammals]] wich sanso be used as a medication.<ref name=AP2014>{{cite book |title=Adenosine Receptors in Neurology and Psychiatry |publisher=Academic Press |isbn=978-0-12-801318-2 |page=XV |year=2014 |url=https://books.google.ca/books?id=pgZ0AwAAQBAJ&pg=PR15 |language=en |access-date=2020-09-28 |archive-date=2021-08-27 |archive-url=https://web.archive.org/web/20210827205455/https://books.google.ca/books?id=pgZ0AwAAQBAJ&pg=PR15 |url-status=live }} {{Webarchive|url=https://web.archive.org/web/20221014135440/https://books.google.ca/books?id=pgZ0AwAAQBAJ&pg=PR15 |date=2022-10-14 }}</ref><ref name=Taylor2000>{{cite book|title=Index Nominum 2000: International Drug Directory|url=https://books.google.com/books?id=5GpcTQD_L2oC&pg=PA18|date=2000|publisher=Taylor & Francis|isbn=978-3-88763-075-1|pages=18–|access-date=2016-01-05|archive-date=2016-05-04|archive-url=https://web.archive.org/web/20160504043944/https://books.google.com/books?id=5GpcTQD_L2oC&pg=PA18|url-status=live}}</ref> As a medication e be used to treat anaa diagnosis certain forms of [[supraventricular tachycardia]] wey no dey improve plus [[vagal maneuver]]s.<ref name=AHFS2020>{{cite web|title=Adenosine|url=https://www.drugs.com/monograph/adenosine.html|publisher=The American Society of Health-System Pharmacists|access-date=Sep 27, 2020|archive-date=December 23, 2014|archive-url=https://web.archive.org/web/20141223143734/http://www.drugs.com/monograph/adenosine.html|url-status=live}} {{Webarchive|url=https://web.archive.org/web/20141223143734/http://www.drugs.com/monograph/adenosine.html |date=December 23, 2014 }}</ref> E generally be used by rapid injection into a vein.<ref name=AHFS2020/> Onset of action be within 40 seconds den effects dey last for less dan 2 minutes.<ref name=Ae2015>{{cite book |last1=Aehlert |first1=Barbara J. |title=ECGs Made Easy - E-Book |publisher=Elsevier Health Sciences |isbn=978-0-323-39150-4 |url=https://www.google.ca/books/edition/ECGs_Made_Easy_E_Book/jg9qBgAAQBAJ?hl=en&gbpv=1&dq=adenosine+onset+of+action&pg=PA116 |page=116 |year=2015 |access-date=29 September 2020 |language=en |archive-date=27 August 2021 |archive-url=https://web.archive.org/web/20210827205456/https://www.google.ca/books/edition/ECGs_Made_Easy_E_Book/jg9qBgAAQBAJ?hl=en&gbpv=1&dq=adenosine+onset+of+action&pg=PA116 |url-status=live }} {{Webarchive|url=https://web.archive.org/web/20210827205456/https://www.google.ca/books/edition/ECGs_Made_Easy_E_Book/jg9qBgAAQBAJ?hl=en&gbpv=1&dq=adenosine+onset+of+action&pg=PA116 |date=27 August 2021 }}</ref>
Common side effects dey include chest pain, feeling faint, shortness of breath, den [[Hypoesthesia|tingling of de skin]].<ref name=AHFS2020/> Serious side effects dey include a worsening [[Arrhythmia|dysrhythmia]] den [[hypotension|low blood pressure]].<ref name=AHFS2020/> While e fi be used during [[pregnancy]], safety no be entirely clear.<ref name=Preg2020>{{cite web |title=Adenosine Use During Pregnancy |url=https://www.drugs.com/pregnancy/adenosine.html |website=Drugs.com |access-date=28 September 2020 |language=en |archive-date=5 December 2020 |archive-url=https://web.archive.org/web/20201205062314/https://www.drugs.com/pregnancy/adenosine.html |url-status=live }} {{Webarchive|url=https://web.archive.org/web/20201205062314/https://www.drugs.com/pregnancy/adenosine.html |date=5 December 2020 }}</ref> Adenosine be one of four [[nucleoside]] building blocks to [[RNA]].<ref name=AP2014/> E dey work by decreasing de frequency by wich electrical signals fi go thru de [[Atrioventricular node|AV node]] of de heart.<ref name=AHFS2020/>
Adenosine be approved for medical use insyd de [[United States]] insyd 1989.<ref name=AHFS2020/> E; however, be studied within living systems since de 1920s.<ref name=AP2014/> Adenosine be available as a [[generic medication]].<ref name=BNF79>{{cite book |title=BNF 79 |date=March 2020 |publisher=Pharmaceutical Press |location=London |isbn=978-0857113658 |page=110}}</ref> It is not expensive.<ref name=Hitch2019>{{Cite book|last=Hitchings|first=Andrew|url=https://books.google.com/books?id=FPx0DwAAQBAJ|title=The Top 100 Drugs: Clinical Pharmacology and Practical Prescribing|last2=Lonsdale|first2=Dagan|last3=Burrage|first3=Daniel|last4=Baker|first4=Emma|date=2019|publisher=Elsevier|isbn=978-0-7020-7442-4|edition=2nd|pages=34-35|language=en|access-date=2021-11-09|archive-date=2021-05-22|archive-url=https://web.archive.org/web/20210522175005/https://books.google.com/books?id=FPx0DwAAQBAJ|url-status=live}}</ref> Insyd de [[United Kingdom]] insyd 2020 a 6 mg dose costs de NHS about a pound.<ref name=BNF79/>
== References ==
<references />
== External links ==
{{Commons}}
{{Authority control}}
[[Category:Adenosine receptor agonists]]
[[Category:Antiarrhythmic agents]]
[[Category:Chemical substances for emergency medicine]]
[[Category:Drugs acting on de cardiovascular system]]
[[Category:Ghrelin receptor agonists]]
[[Category:Nucleosides]]
[[Category:Purines]]
[[Category:Neurotransmitters]]
[[Category:Vasodilators]]
[[Category:Hydroxymethyl compounds]]
[[Category:Translated from MDWiki]]
m5eggb6ul8vsvr8ooz08807xip093x7
114940
114938
2026-10-16T18:44:45Z
DaSupremo
9
Change category
114940
wikitext
text/x-wiki
{{Databox}}
'''Adenosine''' be a [[endogeny (biology)|chemical dem find insyd mammals]] wich sanso be used as a medication.<ref name=AP2014>{{cite book |title=Adenosine Receptors in Neurology and Psychiatry |publisher=Academic Press |isbn=978-0-12-801318-2 |page=XV |year=2014 |url=https://books.google.ca/books?id=pgZ0AwAAQBAJ&pg=PR15 |language=en |access-date=2020-09-28 |archive-date=2021-08-27 |archive-url=https://web.archive.org/web/20210827205455/https://books.google.ca/books?id=pgZ0AwAAQBAJ&pg=PR15 |url-status=live }} {{Webarchive|url=https://web.archive.org/web/20221014135440/https://books.google.ca/books?id=pgZ0AwAAQBAJ&pg=PR15 |date=2022-10-14 }}</ref><ref name=Taylor2000>{{cite book|title=Index Nominum 2000: International Drug Directory|url=https://books.google.com/books?id=5GpcTQD_L2oC&pg=PA18|date=2000|publisher=Taylor & Francis|isbn=978-3-88763-075-1|pages=18–|access-date=2016-01-05|archive-date=2016-05-04|archive-url=https://web.archive.org/web/20160504043944/https://books.google.com/books?id=5GpcTQD_L2oC&pg=PA18|url-status=live}}</ref> As a medication e be used to treat anaa diagnosis certain forms of [[supraventricular tachycardia]] wey no dey improve plus [[vagal maneuver]]s.<ref name=AHFS2020>{{cite web|title=Adenosine|url=https://www.drugs.com/monograph/adenosine.html|publisher=The American Society of Health-System Pharmacists|access-date=Sep 27, 2020|archive-date=December 23, 2014|archive-url=https://web.archive.org/web/20141223143734/http://www.drugs.com/monograph/adenosine.html|url-status=live}} {{Webarchive|url=https://web.archive.org/web/20141223143734/http://www.drugs.com/monograph/adenosine.html |date=December 23, 2014 }}</ref> E generally be used by rapid injection into a vein.<ref name=AHFS2020/> Onset of action be within 40 seconds den effects dey last for less dan 2 minutes.<ref name=Ae2015>{{cite book |last1=Aehlert |first1=Barbara J. |title=ECGs Made Easy - E-Book |publisher=Elsevier Health Sciences |isbn=978-0-323-39150-4 |url=https://www.google.ca/books/edition/ECGs_Made_Easy_E_Book/jg9qBgAAQBAJ?hl=en&gbpv=1&dq=adenosine+onset+of+action&pg=PA116 |page=116 |year=2015 |access-date=29 September 2020 |language=en |archive-date=27 August 2021 |archive-url=https://web.archive.org/web/20210827205456/https://www.google.ca/books/edition/ECGs_Made_Easy_E_Book/jg9qBgAAQBAJ?hl=en&gbpv=1&dq=adenosine+onset+of+action&pg=PA116 |url-status=live }} {{Webarchive|url=https://web.archive.org/web/20210827205456/https://www.google.ca/books/edition/ECGs_Made_Easy_E_Book/jg9qBgAAQBAJ?hl=en&gbpv=1&dq=adenosine+onset+of+action&pg=PA116 |date=27 August 2021 }}</ref>
Common side effects dey include chest pain, feeling faint, shortness of breath, den [[Hypoesthesia|tingling of de skin]].<ref name=AHFS2020/> Serious side effects dey include a worsening [[Arrhythmia|dysrhythmia]] den [[hypotension|low blood pressure]].<ref name=AHFS2020/> While e fi be used during [[pregnancy]], safety no be entirely clear.<ref name=Preg2020>{{cite web |title=Adenosine Use During Pregnancy |url=https://www.drugs.com/pregnancy/adenosine.html |website=Drugs.com |access-date=28 September 2020 |language=en |archive-date=5 December 2020 |archive-url=https://web.archive.org/web/20201205062314/https://www.drugs.com/pregnancy/adenosine.html |url-status=live }} {{Webarchive|url=https://web.archive.org/web/20201205062314/https://www.drugs.com/pregnancy/adenosine.html |date=5 December 2020 }}</ref> Adenosine be one of four [[nucleoside]] building blocks to [[RNA]].<ref name=AP2014/> E dey work by decreasing de frequency by wich electrical signals fi go thru de [[Atrioventricular node|AV node]] of de heart.<ref name=AHFS2020/>
Adenosine be approved for medical use insyd de [[United States]] insyd 1989.<ref name=AHFS2020/> E; however, be studied within living systems since de 1920s.<ref name=AP2014/> Adenosine be available as a [[generic medication]].<ref name=BNF79>{{cite book |title=BNF 79 |date=March 2020 |publisher=Pharmaceutical Press |location=London |isbn=978-0857113658 |page=110}}</ref> It is not expensive.<ref name=Hitch2019>{{Cite book|last=Hitchings|first=Andrew|url=https://books.google.com/books?id=FPx0DwAAQBAJ|title=The Top 100 Drugs: Clinical Pharmacology and Practical Prescribing|last2=Lonsdale|first2=Dagan|last3=Burrage|first3=Daniel|last4=Baker|first4=Emma|date=2019|publisher=Elsevier|isbn=978-0-7020-7442-4|edition=2nd|pages=34-35|language=en|access-date=2021-11-09|archive-date=2021-05-22|archive-url=https://web.archive.org/web/20210522175005/https://books.google.com/books?id=FPx0DwAAQBAJ|url-status=live}}</ref> Insyd de [[United Kingdom]] insyd 2020 a 6 mg dose costs de NHS about a pound.<ref name=BNF79/>
== References ==
<references />
== External links ==
{{Commons}}
{{Authority control}}
[[Category:Adenosine receptor agonists]]
[[Category:Antiarrhythmic agents]]
[[Category:Chemical substances for emergency medicine]]
[[Category:Drugs wey dey act on de cardiovascular system]]
[[Category:Ghrelin receptor agonists]]
[[Category:Nucleosides]]
[[Category:Purines]]
[[Category:Neurotransmitters]]
[[Category:Vasodilators]]
[[Category:Hydroxymethyl compounds]]
[[Category:Translated from MDWiki]]
9brfcn3ln97s4u2s3tfg1g5d1507cd7
Category:Adenosine receptor agonists
14
31037
114939
2026-10-16T18:43:46Z
DaSupremo
9
Fresh category
114939
wikitext
text/x-wiki
phoiac9h4m842xq45sp7s6u21eteeq1
Category:Ghrelin receptor agonists
14
31038
114941
2026-10-16T18:45:08Z
DaSupremo
9
Fresh category
114941
wikitext
text/x-wiki
phoiac9h4m842xq45sp7s6u21eteeq1
Category:Nucleosides
14
31039
114942
2026-10-16T18:45:44Z
DaSupremo
9
Fresh category
114942
wikitext
text/x-wiki
phoiac9h4m842xq45sp7s6u21eteeq1
Category:Purines
14
31040
114943
2026-10-16T18:45:57Z
DaSupremo
9
Fresh category
114943
wikitext
text/x-wiki
phoiac9h4m842xq45sp7s6u21eteeq1
Category:Hydroxymethyl compounds
14
31041
114944
2026-10-16T18:46:08Z
DaSupremo
9
Fresh category
114944
wikitext
text/x-wiki
phoiac9h4m842xq45sp7s6u21eteeq1
Flunitrazepam
0
31042
114945
2026-10-16T18:47:56Z
DaSupremo
9
Created by translating the page [[:mdwiki:Special:Redirect/revision/1502059|Flunitrazepam]] to:gpe #mdwikicx
114945
wikitext
text/x-wiki
[[Category:Translated from MDWiki]]
r0gf7axtnvt68k0p85plnlehx64o08u
114946
114945
2026-10-16T18:54:53Z
DaSupremo
9
Improve article
114946
wikitext
text/x-wiki
{{Databox}}
'''Adenosine''' be a [[endogeny (biology)|chemical dem find insyd mammals]] wich sanso be used as a medication.<ref name=AP2014>{{cite book |title=Adenosine Receptors in Neurology and Psychiatry |publisher=Academic Press |isbn=978-0-12-801318-2 |page=XV |year=2014 |url=https://books.google.ca/books?id=pgZ0AwAAQBAJ&pg=PR15 |language=en |access-date=2020-09-28 |archive-date=2021-08-27 |archive-url=https://web.archive.org/web/20210827205455/https://books.google.ca/books?id=pgZ0AwAAQBAJ&pg=PR15 |url-status=live }} {{Webarchive|url=https://web.archive.org/web/20221014135440/https://books.google.ca/books?id=pgZ0AwAAQBAJ&pg=PR15 |date=2022-10-14 }}</ref><ref name=Taylor2000>{{cite book|title=Index Nominum 2000: International Drug Directory|url=https://books.google.com/books?id=5GpcTQD_L2oC&pg=PA18|date=2000|publisher=Taylor & Francis|isbn=978-3-88763-075-1|pages=18–|access-date=2016-01-05|archive-date=2016-05-04|archive-url=https://web.archive.org/web/20160504043944/https://books.google.com/books?id=5GpcTQD_L2oC&pg=PA18|url-status=live}}</ref> As a medication e be used to treat anaa diagnosis certain forms of [[supraventricular tachycardia]] wey no dey improve plus [[vagal maneuver]]s.<ref name=AHFS2020>{{cite web|title=Adenosine|url=https://www.drugs.com/monograph/adenosine.html|publisher=The American Society of Health-System Pharmacists|access-date=Sep 27, 2020|archive-date=December 23, 2014|archive-url=https://web.archive.org/web/20141223143734/http://www.drugs.com/monograph/adenosine.html|url-status=live}} {{Webarchive|url=https://web.archive.org/web/20141223143734/http://www.drugs.com/monograph/adenosine.html |date=December 23, 2014 }}</ref> E generally be used by rapid injection into a vein.<ref name=AHFS2020/> Onset of action be within 40 seconds den effects dey last for less dan 2 minutes.<ref name=Ae2015>{{cite book |last1=Aehlert |first1=Barbara J. |title=ECGs Made Easy - E-Book |publisher=Elsevier Health Sciences |isbn=978-0-323-39150-4 |url=https://www.google.ca/books/edition/ECGs_Made_Easy_E_Book/jg9qBgAAQBAJ?hl=en&gbpv=1&dq=adenosine+onset+of+action&pg=PA116 |page=116 |year=2015 |access-date=29 September 2020 |language=en |archive-date=27 August 2021 |archive-url=https://web.archive.org/web/20210827205456/https://www.google.ca/books/edition/ECGs_Made_Easy_E_Book/jg9qBgAAQBAJ?hl=en&gbpv=1&dq=adenosine+onset+of+action&pg=PA116 |url-status=live }} {{Webarchive|url=https://web.archive.org/web/20210827205456/https://www.google.ca/books/edition/ECGs_Made_Easy_E_Book/jg9qBgAAQBAJ?hl=en&gbpv=1&dq=adenosine+onset+of+action&pg=PA116 |date=27 August 2021 }}</ref>
== References ==
[[Category:Translated from MDWiki]]
<references />
== External links ==
6yb8z2zsyui1xk4rcqi7ls022f897c3
114947
114946
2026-10-16T19:12:05Z
DaSupremo
9
Improve article
114947
wikitext
text/x-wiki
{{Databox}}
'''Flunitrazepam''', dem sanso know as '''Rohypnol''' among oda names, be a [[benzodiazepine]] wich be used to treat [[insomnia|trouble sleeping]] den to assist plus [[anesthesia]].<ref name="NSW-PSB">{{cite web|url=http://www.health.nsw.gov.au/pharmaceutical/Documents/guide-flunitraz-alpraz.pdf|title=Prescribing of Benzodiazepines Alprazolam and Flunitrazepam|work=Pharmaceutical Services Branch|publisher=New South Wales Health|date=November 2013|access-date=October 4, 2020|archive-date=October 20, 2020|archive-url=https://web.archive.org/web/20201020093546/https://www0.health.nsw.gov.au/pharmaceutical/Documents/guide-flunitraz-alpraz.pdf|url-status=live}}</ref><ref name=Gah2003>{{cite book |last1=Gahlinger |first1=Paul |title=Illegal Drugs |date=2003 |publisher=Penguin |isbn=978-1-4406-5024-6 |page=279 |url=https://books.google.ca/books?id=kPszgXPVQAsC&pg=PA279 |language=en |access-date=October 7, 2020 |archive-date=August 28, 2021 |archive-url=https://web.archive.org/web/20210828085744/https://books.google.ca/books?id=kPszgXPVQAsC&pg=PA279 |url-status=live }}</ref> E no be an initially recommended treatment wey only be recommended for short-term use.<ref name="NSW-PSB"/><ref name=Mu2014>{{cite book |last1=Muir-Cochrane |first1=Eimear |last2=Barkway |first2=Patricia |last3=Nizette |first3=Debra |title=Mosby's Pocketbook of Mental Health - E-Book |date=2014 |publisher=Elsevier Health Sciences |isbn=978-0-7295-8224-7 |page=99 |url=https://books.google.ca/books?id=5DwPBAAAQBAJ&pg=PA99 |language=en |access-date=October 7, 2020 |archive-date=August 28, 2021 |archive-url=https://web.archive.org/web/20210828085744/https://books.google.ca/books?id=5DwPBAAAQBAJ&pg=PA99 |url-status=live }}</ref>
Side effects dey include a risk of abuse, night time eating, confusion, den withdrawal symptoms if dem stop suddenly after long term use.<ref name="NSW-PSB"/><ref name=Mey2016/><ref name=Ig2012/> Insyd high doses decreased efforts to breath den death fi result.<ref name=Ig2012>{{cite book |last1=Ignatavicius |first1=Donna D. |last2=Workman |first2=M. Linda |last3=Winkelman |first3=Chris |title=Clinical Companion for Medical-Surgical Nursing - E-Book: Patient-Centered Collaborative Care |date=2012 |publisher=Elsevier Health Sciences |isbn=978-1-4557-7257-5 |page=81 |url=https://books.google.ca/books?id=lFwCKRCwAGsC&pg=PA81 |language=en |access-date=October 7, 2020 |archive-date=August 28, 2021 |archive-url=https://web.archive.org/web/20210828085745/https://books.google.ca/books?id=lFwCKRCwAGsC&pg=PA81 |url-status=live }}</ref> After prolonged use de medication needs to be slowly stopped.<ref name=Ig2012/>
Flunitrazepam be patented insyd 1962 wey e cam into medical use insyd 1974.<ref name=Fis2006>{{cite book |last1=Fischer |first1=Jnos |last2=Ganellin |first2=C. Robin |title=Analogue-based Drug Discovery |date=2006 |publisher=John Wiley & Sons |isbn=9783527607495 |page=53X |url=https://books.google.com/books?id=FjKfqkaKkAAC&pg=PA53X |access-date=October 4, 2020 |archive-date=August 28, 2021 |archive-url=https://web.archive.org/web/20210828085745/https://www.google.com/books/edition/Analogue_based_Drug_Discovery/FjKfqkaKkAAC?hl=en&gbpv=1&pg=PA53X&printsec=frontcover |url-status=live }}</ref> E no be legally available insyd de [[United States]], [[Australia]], den New Zealand wey e be restricted insyd parts of [[Europe]].<ref name=Mey2016>{{cite book |last1=Aronson |first1=Jeffrey K. |title=Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions |page=364 |date=2016 |publisher=Elsevier |isbn=978-0-444-53716-4 |url=https://books.google.ca/books?id=NOKoBAAAQBAJ&pg=RA2-PA364 |language=en |access-date=October 7, 2020 |archive-date=August 28, 2021 |archive-url=https://web.archive.org/web/20210828085745/https://books.google.ca/books?id=NOKoBAAAQBAJ&pg=RA2-PA364 |url-status=live }}</ref> E be referred to as a [[date rape drug]],<ref>{{Cite journal|last1=Schwartz|first1=R. H.|last2=Milteer|first2=R.|last3=LeBeau|first3=M. A.|date=June 2000|title=Drug-facilitated sexual assault ('date rape')|journal=Southern Medical Journal|volume=93|issue=6|pages=558–561|issn=0038-4348|pmid=10881768|doi=10.1097/00007611-200093060-00002}}</ref><ref>{{Cite journal|last1=Gautam|first1=Lata|last2=Sharratt|first2=Sarah D.|last3=Cole|first3=Michael D.|date=2014-02-19|title=Drug Facilitated Sexual Assault: Detection and Stability of Benzodiazepines in Spiked Drinks Using Gas Chromatography-Mass Spectrometry|journal=PLOS ONE|volume=9|issue=2|pages=e89031|doi=10.1371/journal.pone.0089031|issn=1932-6203|pmc=3929633|pmid=24586489|bibcode=2014PLoSO...989031G}}</ref> though de percentage of reported rape cases insyd wich e be involved be small.<ref name=EU>European Monitoring Centre for Drugs and Drug Addiction [http://www.emcdda.europa.eu/publications/drug-profiles/benzodiazepine Benzodiazepines drug profile] {{Webarchive|url=https://web.archive.org/web/20200227191331/http://www.emcdda.europa.eu/publications/drug-profiles/benzodiazepine |date=February 27, 2020 }}. Page last updated January 8, 2015</ref>
== References ==
<references />
== External links ==
[[Category:Translated from MDWiki]]
q6xwp0c5wvv9pzj4mrbwgwfvvqcgq84
114948
114947
2026-10-16T19:32:45Z
DaSupremo
9
Improve article
114948
wikitext
text/x-wiki
{{Databox}}
'''Flunitrazepam''', dem sanso know as '''Rohypnol''' among oda names, be a [[benzodiazepine]] wich be used to treat [[insomnia|trouble sleeping]] den to assist plus [[anesthesia]].<ref name="NSW-PSB">{{cite web|url=http://www.health.nsw.gov.au/pharmaceutical/Documents/guide-flunitraz-alpraz.pdf|title=Prescribing of Benzodiazepines Alprazolam and Flunitrazepam|work=Pharmaceutical Services Branch|publisher=New South Wales Health|date=November 2013|access-date=October 4, 2020|archive-date=October 20, 2020|archive-url=https://web.archive.org/web/20201020093546/https://www0.health.nsw.gov.au/pharmaceutical/Documents/guide-flunitraz-alpraz.pdf|url-status=live}}</ref><ref name=Gah2003>{{cite book |last1=Gahlinger |first1=Paul |title=Illegal Drugs |date=2003 |publisher=Penguin |isbn=978-1-4406-5024-6 |page=279 |url=https://books.google.ca/books?id=kPszgXPVQAsC&pg=PA279 |language=en |access-date=October 7, 2020 |archive-date=August 28, 2021 |archive-url=https://web.archive.org/web/20210828085744/https://books.google.ca/books?id=kPszgXPVQAsC&pg=PA279 |url-status=live }}</ref> E no be an initially recommended treatment wey only be recommended for short-term use.<ref name="NSW-PSB"/><ref name=Mu2014>{{cite book |last1=Muir-Cochrane |first1=Eimear |last2=Barkway |first2=Patricia |last3=Nizette |first3=Debra |title=Mosby's Pocketbook of Mental Health - E-Book |date=2014 |publisher=Elsevier Health Sciences |isbn=978-0-7295-8224-7 |page=99 |url=https://books.google.ca/books?id=5DwPBAAAQBAJ&pg=PA99 |language=en |access-date=October 7, 2020 |archive-date=August 28, 2021 |archive-url=https://web.archive.org/web/20210828085744/https://books.google.ca/books?id=5DwPBAAAQBAJ&pg=PA99 |url-status=live }}</ref>
Side effects dey include a risk of abuse, night time eating, confusion, den withdrawal symptoms if dem stop suddenly after long term use.<ref name="NSW-PSB"/><ref name=Mey2016/><ref name=Ig2012/> Insyd high doses decreased efforts to breath den death fi result.<ref name=Ig2012>{{cite book |last1=Ignatavicius |first1=Donna D. |last2=Workman |first2=M. Linda |last3=Winkelman |first3=Chris |title=Clinical Companion for Medical-Surgical Nursing - E-Book: Patient-Centered Collaborative Care |date=2012 |publisher=Elsevier Health Sciences |isbn=978-1-4557-7257-5 |page=81 |url=https://books.google.ca/books?id=lFwCKRCwAGsC&pg=PA81 |language=en |access-date=October 7, 2020 |archive-date=August 28, 2021 |archive-url=https://web.archive.org/web/20210828085745/https://books.google.ca/books?id=lFwCKRCwAGsC&pg=PA81 |url-status=live }}</ref> After prolonged use de medication needs to be slowly stopped.<ref name=Ig2012/>
Flunitrazepam be patented insyd 1962 wey e cam into medical use insyd 1974.<ref name=Fis2006>{{cite book |last1=Fischer |first1=Jnos |last2=Ganellin |first2=C. Robin |title=Analogue-based Drug Discovery |date=2006 |publisher=John Wiley & Sons |isbn=9783527607495 |page=53X |url=https://books.google.com/books?id=FjKfqkaKkAAC&pg=PA53X |access-date=October 4, 2020 |archive-date=August 28, 2021 |archive-url=https://web.archive.org/web/20210828085745/https://www.google.com/books/edition/Analogue_based_Drug_Discovery/FjKfqkaKkAAC?hl=en&gbpv=1&pg=PA53X&printsec=frontcover |url-status=live }}</ref> E no be legally available insyd de [[United States]], [[Australia]], den New Zealand wey e be restricted insyd parts of [[Europe]].<ref name=Mey2016>{{cite book |last1=Aronson |first1=Jeffrey K. |title=Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions |page=364 |date=2016 |publisher=Elsevier |isbn=978-0-444-53716-4 |url=https://books.google.ca/books?id=NOKoBAAAQBAJ&pg=RA2-PA364 |language=en |access-date=October 7, 2020 |archive-date=August 28, 2021 |archive-url=https://web.archive.org/web/20210828085745/https://books.google.ca/books?id=NOKoBAAAQBAJ&pg=RA2-PA364 |url-status=live }}</ref> E be referred to as a [[date rape drug]],<ref>{{Cite journal|last1=Schwartz|first1=R. H.|last2=Milteer|first2=R.|last3=LeBeau|first3=M. A.|date=June 2000|title=Drug-facilitated sexual assault ('date rape')|journal=Southern Medical Journal|volume=93|issue=6|pages=558–561|issn=0038-4348|pmid=10881768|doi=10.1097/00007611-200093060-00002}}</ref><ref>{{Cite journal|last1=Gautam|first1=Lata|last2=Sharratt|first2=Sarah D.|last3=Cole|first3=Michael D.|date=2014-02-19|title=Drug Facilitated Sexual Assault: Detection and Stability of Benzodiazepines in Spiked Drinks Using Gas Chromatography-Mass Spectrometry|journal=PLOS ONE|volume=9|issue=2|pages=e89031|doi=10.1371/journal.pone.0089031|issn=1932-6203|pmc=3929633|pmid=24586489|bibcode=2014PLoSO...989031G}}</ref> though de percentage of reported rape cases insyd wich e be involved be small.<ref name=EU>European Monitoring Centre for Drugs and Drug Addiction [http://www.emcdda.europa.eu/publications/drug-profiles/benzodiazepine Benzodiazepines drug profile] {{Webarchive|url=https://web.archive.org/web/20200227191331/http://www.emcdda.europa.eu/publications/drug-profiles/benzodiazepine |date=February 27, 2020 }}. Page last updated January 8, 2015</ref>
== References ==
<references />
== External links ==
{{Commons category|Flunitrazepam}}{{Authority control}}
[[Category:GABAA receptor positive allosteric modulators]]
[[Category:Glycine receptor antagonists]]
[[Category:Designer prodrugs]]
[[Category:Drugs wey Hoffmann-La Roche develop]]
[[Category:Lactams]]
[[Category:Nitrobenzodiazepines]]
[[Category:2-Fluorophenyl compounds]]
[[Category:Drug culture]]
[[Category:Drug-facilitated sexual assault]]
[[Category:Hypnotics]]
[[Category:Translated from MDWiki]]
epy1oct8jxfwifykyjpw05sj66avgq6
Category:Designer prodrugs
14
31043
114949
2026-10-16T19:33:08Z
DaSupremo
9
Fresh category
114949
wikitext
text/x-wiki
phoiac9h4m842xq45sp7s6u21eteeq1
Spironolactone
0
31044
114950
2026-10-16T19:35:21Z
DaSupremo
9
Created by translating the page [[:mdwiki:Special:Redirect/revision/1457157|Spironolactone]] to:gpe #mdwikicx
114950
wikitext
text/x-wiki
[[Category:Translated from MDWiki]]
r0gf7axtnvt68k0p85plnlehx64o08u
114951
114950
2026-10-16T19:43:56Z
DaSupremo
9
Improve article
114951
wikitext
text/x-wiki
{{Databox}}
'''Spironolactone''', dem sell under de brand name '''Aldactone''' among odas, be classed as a [[diuretic]] [[medication]].<ref>{{Cite web |title=Australian Medicines Handbook |url=https://amhonline.amh.net.au/auth |access-date=12 May 2025 |website=amhonline.amh.net.au}}</ref> E fi be used to treat [[edema|fluid build-up]] secof [[hepatic cirrhosis|liver disease]] anaa [[kidney disease]].<ref name=AHFS2015>{{cite web|title=Spironolactone|url=https://www.drugs.com/monograph/spironolactone.html|publisher=The American Society of Health-System Pharmacists|access-date=24 October 2015|url-status=live|archive-url=https://web.archive.org/web/20151116054857/http://www.drugs.com/monograph/spironolactone.html|archive-date=16 November 2015}}</ref> E sanso be used to reduce risk of disease progression, hospitalization, den death secof sam types of heart failure.<ref>{{cite journal | vauthors = Li S, Zhang X, Dong M, Gong S, Shang Z, Jia X, Chen W, Yang J, Li J | title = Effects of spironolactone in heart failure with preserved ejection fraction: A meta-analysis of randomized controlled trials | language = en-US | journal = Medicine | volume = 97 | issue = 35 | article-number = e11942 | date = August 2018 | pmid = 30170387 | pmc = 6392615 | doi = 10.1097/MD.0000000000011942 }}</ref> Oda uses dey include acne den excessive hair growth insyd women, [[hypokalemia|low blood potassium]] wey no dey improve plus [[Potassium#Supplementation|supplementation]], high blood pressure wey be difficult to treat, den early puberty insyd boys.<ref name=AHFS2015/><ref>{{cite journal | vauthors = Friedman AJ | title = Spironolactone for Adult Female Acne | journal = Cutis | volume = 96 | issue = 4 | pages = 216–217 | date = October 2015 | pmid = 27141564 }}</ref><ref>{{cite book | vauthors = Maizes V | date = 2015 | title = Integrative Women's Health | publisher = Oxford University Press | edition = 2 | page = 746 | isbn = 978-0-19-021480-7 | url = https://books.google.com/books?id=uveJCgAAQBAJ&pg=PA746 }}</ref><ref>{{cite journal | vauthors = Sinnott SJ, Tomlinson LA, Root AA, Mathur R, Mansfield KE, Smeeth L, Douglas IJ | title = Comparative effectiveness of fourth-line antihypertensive agents in resistant hypertension: A systematic review and meta-analysis | journal = European Journal of Preventive Cardiology | volume = 24 | issue = 3 | pages = 228–238 | date = February 2017 | pmid = 27856806 | doi = 10.1177/2047487316675194 | url = https://researchonline.lshtm.ac.uk/id/eprint/3157879/1/Comparative%20effectiveness%20of%204th%20line%20anti-hypertensive%20agents%20in%20resistant%20hypertension%3B%20A%20systematic%20review%20and%20meta-analysis%20.pdf }}</ref> E sanso be used to [[Antiandrogen|block de effects]] of [[testosterone]] as a part of [[feminizing hormone therapy]]. Spironolactone usually be available insyd tablets, dem take [[oral administration|by mouth]], though topical forms sanso be available.<ref name=AHFS2015/>
== References ==
[[Category:Translated from MDWiki]]
<references />
== External links ==
49d1qkku4opbpgx7g5rux9hzq0k0r39
114952
114951
2026-10-16T19:49:56Z
DaSupremo
9
Add references
114952
wikitext
text/x-wiki
{{Databox}}
'''Spironolactone''', dem sell under de brand name '''Aldactone''' among odas, be classed as a [[diuretic]] [[medication]].<ref>{{Cite web |title=Australian Medicines Handbook |url=https://amhonline.amh.net.au/auth |access-date=12 May 2025 |website=amhonline.amh.net.au}}</ref> E fi be used to treat [[edema|fluid build-up]] secof [[hepatic cirrhosis|liver disease]] anaa [[kidney disease]].<ref name=AHFS2015>{{cite web|title=Spironolactone|url=https://www.drugs.com/monograph/spironolactone.html|publisher=The American Society of Health-System Pharmacists|access-date=24 October 2015|url-status=live|archive-url=https://web.archive.org/web/20151116054857/http://www.drugs.com/monograph/spironolactone.html|archive-date=16 November 2015}}</ref> E sanso be used to reduce risk of disease progression, hospitalization, den death secof sam types of heart failure.<ref name=":0">{{cite journal |vauthors=Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J |date=September 1999 |title=The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators |journal=The New England Journal of Medicine |volume=341 |issue=10 |pages=709–717 |doi=10.1056/NEJM199909023411001 |pmid=10471456}}</ref><ref>{{cite journal | vauthors = Li S, Zhang X, Dong M, Gong S, Shang Z, Jia X, Chen W, Yang J, Li J | title = Effects of spironolactone in heart failure with preserved ejection fraction: A meta-analysis of randomized controlled trials | language = en-US | journal = Medicine | volume = 97 | issue = 35 | article-number = e11942 | date = August 2018 | pmid = 30170387 | pmc = 6392615 | doi = 10.1097/MD.0000000000011942 }}</ref> Oda uses dey include acne den excessive hair growth insyd women, [[hypokalemia|low blood potassium]] wey no dey improve plus [[Potassium#Supplementation|supplementation]], high blood pressure wey be difficult to treat, den early puberty insyd boys.<ref name=AHFS2015/><ref>{{cite journal | vauthors = Friedman AJ | title = Spironolactone for Adult Female Acne | journal = Cutis | volume = 96 | issue = 4 | pages = 216–217 | date = October 2015 | pmid = 27141564 }}</ref><ref>{{cite book | vauthors = Maizes V | date = 2015 | title = Integrative Women's Health | publisher = Oxford University Press | edition = 2 | page = 746 | isbn = 978-0-19-021480-7 | url = https://books.google.com/books?id=uveJCgAAQBAJ&pg=PA746 }}</ref><ref>{{cite journal | vauthors = Sinnott SJ, Tomlinson LA, Root AA, Mathur R, Mansfield KE, Smeeth L, Douglas IJ | title = Comparative effectiveness of fourth-line antihypertensive agents in resistant hypertension: A systematic review and meta-analysis | journal = European Journal of Preventive Cardiology | volume = 24 | issue = 3 | pages = 228–238 | date = February 2017 | pmid = 27856806 | doi = 10.1177/2047487316675194 | url = https://researchonline.lshtm.ac.uk/id/eprint/3157879/1/Comparative%20effectiveness%20of%204th%20line%20anti-hypertensive%20agents%20in%20resistant%20hypertension%3B%20A%20systematic%20review%20and%20meta-analysis%20.pdf }}</ref> E sanso be used to [[Antiandrogen|block de effects]] of [[testosterone]] as a part of [[feminizing hormone therapy]].<ref name="WPATH-SOC8">{{cite journal |vauthors=Coleman E, Radix AE, Bouman WP, Brown GR, de Vries AL, Deutsch MB, Ettner R, Fraser L, Goodman M, Green J, Hancock AB, Johnson TW, Karasic DH, Knudson GA, Leibowitz SF, Meyer-Bahlburg HF, Monstrey SJ, Motmans J, Nahata L, Nieder TO, Reisner SL, Richards C, Schechter LS, Tangpricha V, Tishelman AC, Van Trotsenburg MA, Winter S, Ducheny K, Adams NJ, Adrián TM, Allen LR, Azul D, Bagga H, Başar K, Bathory DS, Belinky JJ, Berg DR, Berli JU, Bluebond-Langner RO, Bouman MB, Bowers ML, Brassard PJ, Byrne J, Capitán L, Cargill CJ, Carswell JM, Chang SC, Chelvakumar G, Corneil T, Dalke KB, De Cuypere G, de Vries E, Den Heijer M, Devor AH, Dhejne C, D'Marco A, Edmiston EK, Edwards-Leeper L, Ehrbar R, Ehrensaft D, Eisfeld J, Elaut E, Erickson-Schroth L, Feldman JL, Fisher AD, Garcia MM, Gijs L, Green SE, Hall BP, Hardy TL, Irwig MS, Jacobs LA, Janssen AC, Johnson K, Klink DT, Kreukels BP, Kuper LE, Kvach EJ, Malouf MA, Massey R, Mazur T, McLachlan C, Morrison SD, Mosser SW, Neira PM, Nygren U, Oates JM, Obedin-Maliver J, Pagkalos G, Patton J, Phanuphak N, Rachlin K, Reed T, Rider GN, Ristori J, Robbins-Cherry S, Roberts SA, Rodriguez-Wallberg KA, Rosenthal SM, Sabir K, Safer JD, Scheim AI, Seal LJ, Sehoole TJ, Spencer K, St Amand C, Steensma TD, Strang JF, Taylor GB, Tilleman K, T'Sjoen GG, Vala LN, Van Mello NM, Veale JF, Vencill JA, Vincent B, Wesp LM, West MA, Arcelus J |date=19 August 2022 |title=Standards of Care for the Health of Transgender and Gender Diverse People, Version 8 |url= |journal=International Journal of Transgender Health |volume=23 |issue=sup1 |pages=S1–S259 |doi=10.1080/26895269.2022.2100644 |issn=2689-5269 |pmc=9553112 |pmid=36238954 |doi-access=free}}</ref><ref name="HembreeCohen-KettenisGooren2017">{{cite journal |vauthors=Hembree WC, Cohen-Kettenis PT, Gooren L, Hannema SE, Meyer WJ, Murad MH, Rosenthal SM, Safer JD, Tangpricha V, T'Sjoen GG |date=November 2017 |title=Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline |journal=The Journal of Clinical Endocrinology and Metabolism |volume=102 |issue=11 |pages=3869–3903 |doi=10.1210/jc.2017-01658 |pmid=28945902 |s2cid=3726467 |doi-access=free}}</ref><ref name="Deutsch2016">{{cite web |date=17 June 2016 |title=Guidelines for the Primary and Gender-Affirming Care of Transgender and Gender Nonbinary People |url=https://transcare.ucsf.edu/sites/transcare.ucsf.edu/files/Transgender-PGACG-6-17-16.pdf |url-status=bot: unknown |archive-url=https://web.archive.org/web/20251005034705/https://transcare.ucsf.edu/sites/transcare.ucsf.edu/files/Transgender-PGACG-6-17-16.pdf |archive-date=5 October 2025 |access-date=24 April 2026 |publisher=Center of Excellence for Transgender Health |page=28 |edition=2nd |vauthors=Deutsch M |location=University of California, San Francisco}}</ref> Spironolactone usually be available insyd tablets, dem take [[oral administration|by mouth]], though topical forms sanso be available.<ref name=AHFS2015/>
== References ==
[[Category:Translated from MDWiki]]
<references />
== External links ==
9ulr85d9jl1nczgpn82od3mvpumnhma
114953
114952
2026-10-16T19:54:51Z
DaSupremo
9
Improve article
114953
wikitext
text/x-wiki
{{Databox}}
'''Spironolactone''', dem sell under de brand name '''Aldactone''' among odas, be classed as a [[diuretic]] [[medication]].<ref>{{Cite web |title=Australian Medicines Handbook |url=https://amhonline.amh.net.au/auth |access-date=12 May 2025 |website=amhonline.amh.net.au}}</ref> E fi be used to treat [[edema|fluid build-up]] secof [[hepatic cirrhosis|liver disease]] anaa [[kidney disease]].<ref name=AHFS2015>{{cite web|title=Spironolactone|url=https://www.drugs.com/monograph/spironolactone.html|publisher=The American Society of Health-System Pharmacists|access-date=24 October 2015|url-status=live|archive-url=https://web.archive.org/web/20151116054857/http://www.drugs.com/monograph/spironolactone.html|archive-date=16 November 2015}}</ref> E sanso be used to reduce risk of disease progression, hospitalization, den death secof sam types of heart failure.<ref name=":0">{{cite journal |vauthors=Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J |date=September 1999 |title=The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators |journal=The New England Journal of Medicine |volume=341 |issue=10 |pages=709–717 |doi=10.1056/NEJM199909023411001 |pmid=10471456}}</ref><ref>{{cite journal | vauthors = Li S, Zhang X, Dong M, Gong S, Shang Z, Jia X, Chen W, Yang J, Li J | title = Effects of spironolactone in heart failure with preserved ejection fraction: A meta-analysis of randomized controlled trials | language = en-US | journal = Medicine | volume = 97 | issue = 35 | article-number = e11942 | date = August 2018 | pmid = 30170387 | pmc = 6392615 | doi = 10.1097/MD.0000000000011942 }}</ref> Oda uses dey include acne den excessive hair growth insyd women, [[hypokalemia|low blood potassium]] wey no dey improve plus [[Potassium#Supplementation|supplementation]], high blood pressure wey be difficult to treat, den early puberty insyd boys.<ref name=AHFS2015/><ref>{{cite journal | vauthors = Friedman AJ | title = Spironolactone for Adult Female Acne | journal = Cutis | volume = 96 | issue = 4 | pages = 216–217 | date = October 2015 | pmid = 27141564 }}</ref><ref>{{cite book | vauthors = Maizes V | date = 2015 | title = Integrative Women's Health | publisher = Oxford University Press | edition = 2 | page = 746 | isbn = 978-0-19-021480-7 | url = https://books.google.com/books?id=uveJCgAAQBAJ&pg=PA746 }}</ref><ref>{{cite journal | vauthors = Sinnott SJ, Tomlinson LA, Root AA, Mathur R, Mansfield KE, Smeeth L, Douglas IJ | title = Comparative effectiveness of fourth-line antihypertensive agents in resistant hypertension: A systematic review and meta-analysis | journal = European Journal of Preventive Cardiology | volume = 24 | issue = 3 | pages = 228–238 | date = February 2017 | pmid = 27856806 | doi = 10.1177/2047487316675194 | url = https://researchonline.lshtm.ac.uk/id/eprint/3157879/1/Comparative%20effectiveness%20of%204th%20line%20anti-hypertensive%20agents%20in%20resistant%20hypertension%3B%20A%20systematic%20review%20and%20meta-analysis%20.pdf }}</ref> E sanso be used to [[Antiandrogen|block de effects]] of [[testosterone]] as a part of [[feminizing hormone therapy]].<ref name="WPATH-SOC8">{{cite journal |vauthors=Coleman E, Radix AE, Bouman WP, Brown GR, de Vries AL, Deutsch MB, Ettner R, Fraser L, Goodman M, Green J, Hancock AB, Johnson TW, Karasic DH, Knudson GA, Leibowitz SF, Meyer-Bahlburg HF, Monstrey SJ, Motmans J, Nahata L, Nieder TO, Reisner SL, Richards C, Schechter LS, Tangpricha V, Tishelman AC, Van Trotsenburg MA, Winter S, Ducheny K, Adams NJ, Adrián TM, Allen LR, Azul D, Bagga H, Başar K, Bathory DS, Belinky JJ, Berg DR, Berli JU, Bluebond-Langner RO, Bouman MB, Bowers ML, Brassard PJ, Byrne J, Capitán L, Cargill CJ, Carswell JM, Chang SC, Chelvakumar G, Corneil T, Dalke KB, De Cuypere G, de Vries E, Den Heijer M, Devor AH, Dhejne C, D'Marco A, Edmiston EK, Edwards-Leeper L, Ehrbar R, Ehrensaft D, Eisfeld J, Elaut E, Erickson-Schroth L, Feldman JL, Fisher AD, Garcia MM, Gijs L, Green SE, Hall BP, Hardy TL, Irwig MS, Jacobs LA, Janssen AC, Johnson K, Klink DT, Kreukels BP, Kuper LE, Kvach EJ, Malouf MA, Massey R, Mazur T, McLachlan C, Morrison SD, Mosser SW, Neira PM, Nygren U, Oates JM, Obedin-Maliver J, Pagkalos G, Patton J, Phanuphak N, Rachlin K, Reed T, Rider GN, Ristori J, Robbins-Cherry S, Roberts SA, Rodriguez-Wallberg KA, Rosenthal SM, Sabir K, Safer JD, Scheim AI, Seal LJ, Sehoole TJ, Spencer K, St Amand C, Steensma TD, Strang JF, Taylor GB, Tilleman K, T'Sjoen GG, Vala LN, Van Mello NM, Veale JF, Vencill JA, Vincent B, Wesp LM, West MA, Arcelus J |date=19 August 2022 |title=Standards of Care for the Health of Transgender and Gender Diverse People, Version 8 |url= |journal=International Journal of Transgender Health |volume=23 |issue=sup1 |pages=S1–S259 |doi=10.1080/26895269.2022.2100644 |issn=2689-5269 |pmc=9553112 |pmid=36238954 |doi-access=free}}</ref><ref name="HembreeCohen-KettenisGooren2017">{{cite journal |vauthors=Hembree WC, Cohen-Kettenis PT, Gooren L, Hannema SE, Meyer WJ, Murad MH, Rosenthal SM, Safer JD, Tangpricha V, T'Sjoen GG |date=November 2017 |title=Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline |journal=The Journal of Clinical Endocrinology and Metabolism |volume=102 |issue=11 |pages=3869–3903 |doi=10.1210/jc.2017-01658 |pmid=28945902 |s2cid=3726467 |doi-access=free}}</ref><ref name="Deutsch2016">{{cite web |date=17 June 2016 |title=Guidelines for the Primary and Gender-Affirming Care of Transgender and Gender Nonbinary People |url=https://transcare.ucsf.edu/sites/transcare.ucsf.edu/files/Transgender-PGACG-6-17-16.pdf |url-status=bot: unknown |archive-url=https://web.archive.org/web/20251005034705/https://transcare.ucsf.edu/sites/transcare.ucsf.edu/files/Transgender-PGACG-6-17-16.pdf |archive-date=5 October 2025 |access-date=24 April 2026 |publisher=Center of Excellence for Transgender Health |page=28 |edition=2nd |vauthors=Deutsch M |location=University of California, San Francisco}}</ref> Spironolactone usually be available insyd tablets, dem take [[oral administration|by mouth]], though topical forms sanso be available.<ref name=AHFS2015/>
Common [[side effect]]s dey include [[electrolyte abnormalities]], particularly [[hyperkalemia|high blood potassium]], nausea, vomiting, headache, rashes, den a decreased desire for sex.<ref name=AHFS2015/> Insyd those plus liver anaa kidney problems, extra care for be taken.<ref name=AHFS2015/>
If dem take during pregnancy, sam animal studies dey suggest say spironolactone fi affect de development of sex organs insyd babies.<ref name="pmid303522802">{{cite journal |vauthors=Liszewski W, Boull C |date=April 2019 |title=Lack of evidence for feminization of males exposed to spironolactone in utero: A systematic review |journal=Journal of the American Academy of Dermatology |volume=80 |issue=4 |pages=1147–1148 |doi=10.1016/j.jaad.2018.10.023 |pmid=30352280 |s2cid=53022388 |doi-access=free |title-link=doi}}</ref> While na dis no occur insyd de few human studies available,<ref name="pmid303522802" /><ref name="pmid271569052">{{cite journal |vauthors=Landau E, Amar L |date=June 2016 |title=Primary aldosteronism and pregnancy |journal=Annales d'Endocrinologie |volume=77 |issue=2 |pages=148–160 |doi=10.1016/j.ando.2016.04.009 |pmid=27156905}}</ref><ref>{{cite journal | vauthors = Deng N, Zhong J, Deng Z, Chen M, Yan L, Li H, Han J, Tao E | title = Case report: A pregnant woman accidental treated with spironolactone in mid-gestation | journal = Frontiers in Pharmacology | volume = 15 | article-number = 1404251 | date = 25 July 2024 | pmid = 39119600 | pmc = 11306061 | doi = 10.3389/fphar.2024.1404251 | doi-access = free }}</ref> women wey be pregnant anaa wey dey consider pregnancy for discuss spironolactone use plus dema doctor secof de theoretical risk.<ref name="pmid271569052" />
== References ==
<references />
== External links ==
[[Category:Translated from MDWiki]]
8y3ykenyp00qa8643xdejbobzsxcw4m
114954
114953
2026-10-16T19:57:30Z
DaSupremo
9
Improve article
114954
wikitext
text/x-wiki
{{Databox}}
'''Spironolactone''', dem sell under de brand name '''Aldactone''' among odas, be classed as a [[diuretic]] [[medication]].<ref>{{Cite web |title=Australian Medicines Handbook |url=https://amhonline.amh.net.au/auth |access-date=12 May 2025 |website=amhonline.amh.net.au}}</ref> E fi be used to treat [[edema|fluid build-up]] secof [[hepatic cirrhosis|liver disease]] anaa [[kidney disease]].<ref name=AHFS2015>{{cite web|title=Spironolactone|url=https://www.drugs.com/monograph/spironolactone.html|publisher=The American Society of Health-System Pharmacists|access-date=24 October 2015|url-status=live|archive-url=https://web.archive.org/web/20151116054857/http://www.drugs.com/monograph/spironolactone.html|archive-date=16 November 2015}}</ref> E sanso be used to reduce risk of disease progression, hospitalization, den death secof sam types of heart failure.<ref name=":0">{{cite journal |vauthors=Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J |date=September 1999 |title=The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators |journal=The New England Journal of Medicine |volume=341 |issue=10 |pages=709–717 |doi=10.1056/NEJM199909023411001 |pmid=10471456}}</ref><ref>{{cite journal | vauthors = Li S, Zhang X, Dong M, Gong S, Shang Z, Jia X, Chen W, Yang J, Li J | title = Effects of spironolactone in heart failure with preserved ejection fraction: A meta-analysis of randomized controlled trials | language = en-US | journal = Medicine | volume = 97 | issue = 35 | article-number = e11942 | date = August 2018 | pmid = 30170387 | pmc = 6392615 | doi = 10.1097/MD.0000000000011942 }}</ref> Oda uses dey include acne den excessive hair growth insyd women, [[hypokalemia|low blood potassium]] wey no dey improve plus [[Potassium#Supplementation|supplementation]], high blood pressure wey be difficult to treat, den early puberty insyd boys.<ref name=AHFS2015/><ref>{{cite journal | vauthors = Friedman AJ | title = Spironolactone for Adult Female Acne | journal = Cutis | volume = 96 | issue = 4 | pages = 216–217 | date = October 2015 | pmid = 27141564 }}</ref><ref>{{cite book | vauthors = Maizes V | date = 2015 | title = Integrative Women's Health | publisher = Oxford University Press | edition = 2 | page = 746 | isbn = 978-0-19-021480-7 | url = https://books.google.com/books?id=uveJCgAAQBAJ&pg=PA746 }}</ref><ref>{{cite journal | vauthors = Sinnott SJ, Tomlinson LA, Root AA, Mathur R, Mansfield KE, Smeeth L, Douglas IJ | title = Comparative effectiveness of fourth-line antihypertensive agents in resistant hypertension: A systematic review and meta-analysis | journal = European Journal of Preventive Cardiology | volume = 24 | issue = 3 | pages = 228–238 | date = February 2017 | pmid = 27856806 | doi = 10.1177/2047487316675194 | url = https://researchonline.lshtm.ac.uk/id/eprint/3157879/1/Comparative%20effectiveness%20of%204th%20line%20anti-hypertensive%20agents%20in%20resistant%20hypertension%3B%20A%20systematic%20review%20and%20meta-analysis%20.pdf }}</ref> E sanso be used to [[Antiandrogen|block de effects]] of [[testosterone]] as a part of [[feminizing hormone therapy]].<ref name="WPATH-SOC8">{{cite journal |vauthors=Coleman E, Radix AE, Bouman WP, Brown GR, de Vries AL, Deutsch MB, Ettner R, Fraser L, Goodman M, Green J, Hancock AB, Johnson TW, Karasic DH, Knudson GA, Leibowitz SF, Meyer-Bahlburg HF, Monstrey SJ, Motmans J, Nahata L, Nieder TO, Reisner SL, Richards C, Schechter LS, Tangpricha V, Tishelman AC, Van Trotsenburg MA, Winter S, Ducheny K, Adams NJ, Adrián TM, Allen LR, Azul D, Bagga H, Başar K, Bathory DS, Belinky JJ, Berg DR, Berli JU, Bluebond-Langner RO, Bouman MB, Bowers ML, Brassard PJ, Byrne J, Capitán L, Cargill CJ, Carswell JM, Chang SC, Chelvakumar G, Corneil T, Dalke KB, De Cuypere G, de Vries E, Den Heijer M, Devor AH, Dhejne C, D'Marco A, Edmiston EK, Edwards-Leeper L, Ehrbar R, Ehrensaft D, Eisfeld J, Elaut E, Erickson-Schroth L, Feldman JL, Fisher AD, Garcia MM, Gijs L, Green SE, Hall BP, Hardy TL, Irwig MS, Jacobs LA, Janssen AC, Johnson K, Klink DT, Kreukels BP, Kuper LE, Kvach EJ, Malouf MA, Massey R, Mazur T, McLachlan C, Morrison SD, Mosser SW, Neira PM, Nygren U, Oates JM, Obedin-Maliver J, Pagkalos G, Patton J, Phanuphak N, Rachlin K, Reed T, Rider GN, Ristori J, Robbins-Cherry S, Roberts SA, Rodriguez-Wallberg KA, Rosenthal SM, Sabir K, Safer JD, Scheim AI, Seal LJ, Sehoole TJ, Spencer K, St Amand C, Steensma TD, Strang JF, Taylor GB, Tilleman K, T'Sjoen GG, Vala LN, Van Mello NM, Veale JF, Vencill JA, Vincent B, Wesp LM, West MA, Arcelus J |date=19 August 2022 |title=Standards of Care for the Health of Transgender and Gender Diverse People, Version 8 |url= |journal=International Journal of Transgender Health |volume=23 |issue=sup1 |pages=S1–S259 |doi=10.1080/26895269.2022.2100644 |issn=2689-5269 |pmc=9553112 |pmid=36238954 |doi-access=free}}</ref><ref name="HembreeCohen-KettenisGooren2017">{{cite journal |vauthors=Hembree WC, Cohen-Kettenis PT, Gooren L, Hannema SE, Meyer WJ, Murad MH, Rosenthal SM, Safer JD, Tangpricha V, T'Sjoen GG |date=November 2017 |title=Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline |journal=The Journal of Clinical Endocrinology and Metabolism |volume=102 |issue=11 |pages=3869–3903 |doi=10.1210/jc.2017-01658 |pmid=28945902 |s2cid=3726467 |doi-access=free}}</ref><ref name="Deutsch2016">{{cite web |date=17 June 2016 |title=Guidelines for the Primary and Gender-Affirming Care of Transgender and Gender Nonbinary People |url=https://transcare.ucsf.edu/sites/transcare.ucsf.edu/files/Transgender-PGACG-6-17-16.pdf |url-status=bot: unknown |archive-url=https://web.archive.org/web/20251005034705/https://transcare.ucsf.edu/sites/transcare.ucsf.edu/files/Transgender-PGACG-6-17-16.pdf |archive-date=5 October 2025 |access-date=24 April 2026 |publisher=Center of Excellence for Transgender Health |page=28 |edition=2nd |vauthors=Deutsch M |location=University of California, San Francisco}}</ref> Spironolactone usually be available insyd tablets, dem take [[oral administration|by mouth]], though topical forms sanso be available.<ref name=AHFS2015/>
Common [[side effect]]s dey include [[electrolyte abnormalities]], particularly [[hyperkalemia|high blood potassium]], nausea, vomiting, headache, rashes, den a decreased desire for sex.<ref name=AHFS2015/> Insyd those plus liver anaa kidney problems, extra care for be taken.<ref name=AHFS2015/>
If dem take during pregnancy, sam animal studies dey suggest say spironolactone fi affect de development of sex organs insyd babies.<ref name="pmid303522802">{{cite journal |vauthors=Liszewski W, Boull C |date=April 2019 |title=Lack of evidence for feminization of males exposed to spironolactone in utero: A systematic review |journal=Journal of the American Academy of Dermatology |volume=80 |issue=4 |pages=1147–1148 |doi=10.1016/j.jaad.2018.10.023 |pmid=30352280 |s2cid=53022388 |doi-access=free |title-link=doi}}</ref> While na dis no occur insyd de few human studies available,<ref name="pmid303522802" /><ref name="pmid271569052">{{cite journal |vauthors=Landau E, Amar L |date=June 2016 |title=Primary aldosteronism and pregnancy |journal=Annales d'Endocrinologie |volume=77 |issue=2 |pages=148–160 |doi=10.1016/j.ando.2016.04.009 |pmid=27156905}}</ref><ref>{{cite journal | vauthors = Deng N, Zhong J, Deng Z, Chen M, Yan L, Li H, Han J, Tao E | title = Case report: A pregnant woman accidental treated with spironolactone in mid-gestation | journal = Frontiers in Pharmacology | volume = 15 | article-number = 1404251 | date = 25 July 2024 | pmid = 39119600 | pmc = 11306061 | doi = 10.3389/fphar.2024.1404251 | doi-access = free }}</ref> women wey be pregnant anaa wey dey consider pregnancy for discuss spironolactone use plus dema doctor secof de theoretical risk.<ref name="pmid271569052" />
Spironolactone be a [[steroid]] wey dey [[receptor antagonist|block]] de effects of de [[hormone]]s [[aldosterone]], den to a lesser degree, testosterone, wey dey cause sam [[estrogen (medication)|estrogen]]-like effects.<ref name="Burinkul_2021">{{cite journal | vauthors = Burinkul S, Panyakhamlerd K, Suwan A, Tuntiviriyapun P, Wainipitapong S | title = Anti-Androgenic Effects Comparison Between Cyproterone Acetate and Spironolactone in Transgender Women: A Randomized Controlled Trial | journal = The Journal of Sexual Medicine | volume = 18 | issue = 7 | pages = 1299–1307 | date = July 2021 | pmid = 34274044 | doi = 10.1016/j.jsxm.2021.05.003 }}</ref>{{Unreliable source?|reason=primary|date=July 2024}}<ref name="Sehgal_2023">{{cite journal | vauthors = Sehgal I | title = Review of adult gender transition medications: mechanisms, efficacy measures, and pharmacogenomic considerations | journal = Frontiers in Endocrinology | volume = 14 | issue = | article-number = 1184024 | date = 2023 | pmid = 37476490 | pmc = 10355117 | doi = 10.3389/fendo.2023.1184024 | doi-access = free }}</ref><ref name="AHFS2015" /><ref name="Deedwania2014">{{cite book | vauthors = Deedwania PC | date = 30 January 2014 | title = Drug & Device Selection in Heart Failure | publisher = JP Medical Ltd | pages = 47– | isbn = 978-93-5090-723-8 | url = https://books.google.com/books?id=k8bUAgAAQBAJ&pg=PA47 | access-date = 5 July 2017 | archive-date = 7 October 2022 | archive-url = https://web.archive.org/web/20221007092257/https://books.google.com/books?id=k8bUAgAAQBAJ&pg=PA47 | url-status = live }}</ref> Spironolactone dey belong to a class of medications dem know as [[potassium-sparing diuretic]]s.<ref name="AHFS2015" />
== References ==
<references />
== External links ==
[[Category:Translated from MDWiki]]
td0v9uxepvx4isfzu8bm9dje9deixuh
114955
114954
2026-10-16T20:00:41Z
DaSupremo
9
Improve article
114955
wikitext
text/x-wiki
{{Databox}}
'''Spironolactone''', dem sell under de brand name '''Aldactone''' among odas, be classed as a [[diuretic]] [[medication]].<ref>{{Cite web |title=Australian Medicines Handbook |url=https://amhonline.amh.net.au/auth |access-date=12 May 2025 |website=amhonline.amh.net.au}}</ref> E fi be used to treat [[edema|fluid build-up]] secof [[hepatic cirrhosis|liver disease]] anaa [[kidney disease]].<ref name=AHFS2015>{{cite web|title=Spironolactone|url=https://www.drugs.com/monograph/spironolactone.html|publisher=The American Society of Health-System Pharmacists|access-date=24 October 2015|url-status=live|archive-url=https://web.archive.org/web/20151116054857/http://www.drugs.com/monograph/spironolactone.html|archive-date=16 November 2015}}</ref> E sanso be used to reduce risk of disease progression, hospitalization, den death secof sam types of heart failure.<ref name=":0">{{cite journal |vauthors=Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J |date=September 1999 |title=The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators |journal=The New England Journal of Medicine |volume=341 |issue=10 |pages=709–717 |doi=10.1056/NEJM199909023411001 |pmid=10471456}}</ref><ref>{{cite journal | vauthors = Li S, Zhang X, Dong M, Gong S, Shang Z, Jia X, Chen W, Yang J, Li J | title = Effects of spironolactone in heart failure with preserved ejection fraction: A meta-analysis of randomized controlled trials | language = en-US | journal = Medicine | volume = 97 | issue = 35 | article-number = e11942 | date = August 2018 | pmid = 30170387 | pmc = 6392615 | doi = 10.1097/MD.0000000000011942 }}</ref> Oda uses dey include acne den excessive hair growth insyd women, [[hypokalemia|low blood potassium]] wey no dey improve plus [[Potassium#Supplementation|supplementation]], high blood pressure wey be difficult to treat, den early puberty insyd boys.<ref name=AHFS2015/><ref>{{cite journal | vauthors = Friedman AJ | title = Spironolactone for Adult Female Acne | journal = Cutis | volume = 96 | issue = 4 | pages = 216–217 | date = October 2015 | pmid = 27141564 }}</ref><ref>{{cite book | vauthors = Maizes V | date = 2015 | title = Integrative Women's Health | publisher = Oxford University Press | edition = 2 | page = 746 | isbn = 978-0-19-021480-7 | url = https://books.google.com/books?id=uveJCgAAQBAJ&pg=PA746 }}</ref><ref>{{cite journal | vauthors = Sinnott SJ, Tomlinson LA, Root AA, Mathur R, Mansfield KE, Smeeth L, Douglas IJ | title = Comparative effectiveness of fourth-line antihypertensive agents in resistant hypertension: A systematic review and meta-analysis | journal = European Journal of Preventive Cardiology | volume = 24 | issue = 3 | pages = 228–238 | date = February 2017 | pmid = 27856806 | doi = 10.1177/2047487316675194 | url = https://researchonline.lshtm.ac.uk/id/eprint/3157879/1/Comparative%20effectiveness%20of%204th%20line%20anti-hypertensive%20agents%20in%20resistant%20hypertension%3B%20A%20systematic%20review%20and%20meta-analysis%20.pdf }}</ref> E sanso be used to [[Antiandrogen|block de effects]] of [[testosterone]] as a part of [[feminizing hormone therapy]].<ref name="WPATH-SOC8">{{cite journal |vauthors=Coleman E, Radix AE, Bouman WP, Brown GR, de Vries AL, Deutsch MB, Ettner R, Fraser L, Goodman M, Green J, Hancock AB, Johnson TW, Karasic DH, Knudson GA, Leibowitz SF, Meyer-Bahlburg HF, Monstrey SJ, Motmans J, Nahata L, Nieder TO, Reisner SL, Richards C, Schechter LS, Tangpricha V, Tishelman AC, Van Trotsenburg MA, Winter S, Ducheny K, Adams NJ, Adrián TM, Allen LR, Azul D, Bagga H, Başar K, Bathory DS, Belinky JJ, Berg DR, Berli JU, Bluebond-Langner RO, Bouman MB, Bowers ML, Brassard PJ, Byrne J, Capitán L, Cargill CJ, Carswell JM, Chang SC, Chelvakumar G, Corneil T, Dalke KB, De Cuypere G, de Vries E, Den Heijer M, Devor AH, Dhejne C, D'Marco A, Edmiston EK, Edwards-Leeper L, Ehrbar R, Ehrensaft D, Eisfeld J, Elaut E, Erickson-Schroth L, Feldman JL, Fisher AD, Garcia MM, Gijs L, Green SE, Hall BP, Hardy TL, Irwig MS, Jacobs LA, Janssen AC, Johnson K, Klink DT, Kreukels BP, Kuper LE, Kvach EJ, Malouf MA, Massey R, Mazur T, McLachlan C, Morrison SD, Mosser SW, Neira PM, Nygren U, Oates JM, Obedin-Maliver J, Pagkalos G, Patton J, Phanuphak N, Rachlin K, Reed T, Rider GN, Ristori J, Robbins-Cherry S, Roberts SA, Rodriguez-Wallberg KA, Rosenthal SM, Sabir K, Safer JD, Scheim AI, Seal LJ, Sehoole TJ, Spencer K, St Amand C, Steensma TD, Strang JF, Taylor GB, Tilleman K, T'Sjoen GG, Vala LN, Van Mello NM, Veale JF, Vencill JA, Vincent B, Wesp LM, West MA, Arcelus J |date=19 August 2022 |title=Standards of Care for the Health of Transgender and Gender Diverse People, Version 8 |url= |journal=International Journal of Transgender Health |volume=23 |issue=sup1 |pages=S1–S259 |doi=10.1080/26895269.2022.2100644 |issn=2689-5269 |pmc=9553112 |pmid=36238954 |doi-access=free}}</ref><ref name="HembreeCohen-KettenisGooren2017">{{cite journal |vauthors=Hembree WC, Cohen-Kettenis PT, Gooren L, Hannema SE, Meyer WJ, Murad MH, Rosenthal SM, Safer JD, Tangpricha V, T'Sjoen GG |date=November 2017 |title=Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline |journal=The Journal of Clinical Endocrinology and Metabolism |volume=102 |issue=11 |pages=3869–3903 |doi=10.1210/jc.2017-01658 |pmid=28945902 |s2cid=3726467 |doi-access=free}}</ref><ref name="Deutsch2016">{{cite web |date=17 June 2016 |title=Guidelines for the Primary and Gender-Affirming Care of Transgender and Gender Nonbinary People |url=https://transcare.ucsf.edu/sites/transcare.ucsf.edu/files/Transgender-PGACG-6-17-16.pdf |url-status=bot: unknown |archive-url=https://web.archive.org/web/20251005034705/https://transcare.ucsf.edu/sites/transcare.ucsf.edu/files/Transgender-PGACG-6-17-16.pdf |archive-date=5 October 2025 |access-date=24 April 2026 |publisher=Center of Excellence for Transgender Health |page=28 |edition=2nd |vauthors=Deutsch M |location=University of California, San Francisco}}</ref> Spironolactone usually be available insyd tablets, dem take [[oral administration|by mouth]], though topical forms sanso be available.<ref name=AHFS2015/>
Common [[side effect]]s dey include [[electrolyte abnormalities]], particularly [[hyperkalemia|high blood potassium]], nausea, vomiting, headache, rashes, den a decreased desire for sex.<ref name=AHFS2015/> Insyd those plus liver anaa kidney problems, extra care for be taken.<ref name=AHFS2015/>
If dem take during pregnancy, sam animal studies dey suggest say spironolactone fi affect de development of sex organs insyd babies.<ref name="pmid303522802">{{cite journal |vauthors=Liszewski W, Boull C |date=April 2019 |title=Lack of evidence for feminization of males exposed to spironolactone in utero: A systematic review |journal=Journal of the American Academy of Dermatology |volume=80 |issue=4 |pages=1147–1148 |doi=10.1016/j.jaad.2018.10.023 |pmid=30352280 |s2cid=53022388 |doi-access=free |title-link=doi}}</ref> While na dis no occur insyd de few human studies available,<ref name="pmid303522802" /><ref name="pmid271569052">{{cite journal |vauthors=Landau E, Amar L |date=June 2016 |title=Primary aldosteronism and pregnancy |journal=Annales d'Endocrinologie |volume=77 |issue=2 |pages=148–160 |doi=10.1016/j.ando.2016.04.009 |pmid=27156905}}</ref><ref>{{cite journal | vauthors = Deng N, Zhong J, Deng Z, Chen M, Yan L, Li H, Han J, Tao E | title = Case report: A pregnant woman accidental treated with spironolactone in mid-gestation | journal = Frontiers in Pharmacology | volume = 15 | article-number = 1404251 | date = 25 July 2024 | pmid = 39119600 | pmc = 11306061 | doi = 10.3389/fphar.2024.1404251 | doi-access = free }}</ref> women wey be pregnant anaa wey dey consider pregnancy for discuss spironolactone use plus dema doctor secof de theoretical risk.<ref name="pmid271569052" />
Spironolactone be a [[steroid]] wey dey [[receptor antagonist|block]] de effects of de [[hormone]]s [[aldosterone]], den to a lesser degree, testosterone, wey dey cause sam [[estrogen (medication)|estrogen]]-like effects.<ref name="Burinkul_2021">{{cite journal | vauthors = Burinkul S, Panyakhamlerd K, Suwan A, Tuntiviriyapun P, Wainipitapong S | title = Anti-Androgenic Effects Comparison Between Cyproterone Acetate and Spironolactone in Transgender Women: A Randomized Controlled Trial | journal = The Journal of Sexual Medicine | volume = 18 | issue = 7 | pages = 1299–1307 | date = July 2021 | pmid = 34274044 | doi = 10.1016/j.jsxm.2021.05.003 }}</ref>{{Unreliable source?|reason=primary|date=July 2024}}<ref name="Sehgal_2023">{{cite journal | vauthors = Sehgal I | title = Review of adult gender transition medications: mechanisms, efficacy measures, and pharmacogenomic considerations | journal = Frontiers in Endocrinology | volume = 14 | issue = | article-number = 1184024 | date = 2023 | pmid = 37476490 | pmc = 10355117 | doi = 10.3389/fendo.2023.1184024 | doi-access = free }}</ref><ref name="AHFS2015" /><ref name="Deedwania2014">{{cite book | vauthors = Deedwania PC | date = 30 January 2014 | title = Drug & Device Selection in Heart Failure | publisher = JP Medical Ltd | pages = 47– | isbn = 978-93-5090-723-8 | url = https://books.google.com/books?id=k8bUAgAAQBAJ&pg=PA47 | access-date = 5 July 2017 | archive-date = 7 October 2022 | archive-url = https://web.archive.org/web/20221007092257/https://books.google.com/books?id=k8bUAgAAQBAJ&pg=PA47 | url-status = live }}</ref> Spironolactone dey belong to a class of medications dem know as [[potassium-sparing diuretic]]s.<ref name="AHFS2015" />
Spironolactone be discovered insyd 1957, wey na dem introduce am insyd 1959.<ref name="OttowWeinmann2008">{{cite book | vauthors = Ottow E, Weinmann H | date = 9 July 2008 | title = Nuclear Receptors As Drug Targets | publisher = John Wiley & Sons | page = 410 | isbn = 978-3-527-62330-3 | url = https://books.google.com/books?id=iATfLbPgRugC&pg=PA410 | access-date = 28 May 2012 | archive-date = 21 June 2013 | archive-url = https://web.archive.org/web/20130621121614/http://books.google.com/books?id=iATfLbPgRugC&pg=PA410 | url-status = live }}</ref><ref name="Wermuth2008">{{cite book | vauthors = Wermuth CG | date = 24 July 2008 | title = The Practice of Medicinal Chemistry | publisher = Academic Press | page = 34 | isbn = 978-0-12-374194-3 | url = https://books.google.com/books?id=Qmt1_DQkCpEC&pg=PA34 | access-date = 27 May 2012 | archive-date = 21 June 2013 | archive-url = https://web.archive.org/web/20130621115634/http://books.google.com/books?id=Qmt1_DQkCpEC&pg=PA34 | url-status = live | author-link = Camille Georges Wermuth }}</ref><ref name="Sittig1988">{{cite book | vauthors = Sittig M | year = 1988 | title = Pharmaceutical Manufacturing Encyclopedia | publisher = William Andrew | page = 1385 | isbn = 978-0-8155-1144-1 | url = https://books.google.com/books?id=XCsJgUnclbcC&pg=PA1385 | access-date = 27 May 2012 | archive-date = 20 June 2013 | archive-url = https://web.archive.org/web/20130620225714/http://books.google.com/books?id=XCsJgUnclbcC&pg=PA1385 | url-status = live }}</ref> E dey on de [[WHO Model List of Essential Medicines|World Health Organization's List of Essential Medicines]].<ref name="WHO24th">{{cite book | vauthors = ((World Health Organization)) | year = 2025 | title = The selection and use of essential medicines, 2025: WHO Model List of Essential Medicines, 24th list | publisher = World Health Organization | doi = 10.2471/B09474 | doi-access = free | hdl = 10665/382243 | author-link = World Health Organization | location = Geneva | hdl-access = free | id = License: CC BY-NC-SA 3.0 IGO }}</ref> E be available as a [[generic medication]].<ref name=AHFS2015/> Insyd 2023, na e be de 52nd most commonly prescribed medication insyd de United States, plus more dan 12{{nbsp}}million prescriptions.<ref>{{cite web | title=Top 300 of 2023 | url=https://clincalc.com/DrugStats/Top300Drugs.aspx | website=ClinCalc | access-date=12 August 2025 | archive-date=12 August 2025 | archive-url=https://web.archive.org/web/20250812130026/https://clincalc.com/DrugStats/Top300Drugs.aspx | url-status=live }}</ref><ref>{{cite web | title = Spironolactone Drug Usage Statistics, United States, 2014 - 2023 | website = ClinCalc | url = https://clincalc.com/DrugStats/Drugs/Spironolactone | access-date = 18 August 2025 }}</ref> Spironolactone get a history of use insyd de trans community.<ref>{{cite journal | vauthors = Prior JC, Vigna YM, Watson D | title = Spironolactone with Physiological Female Steroids for Presurgical Therapy of Male-To-Female Transsexualism | journal = Archives of Sexual Behavior | volume = 18 | issue = 1 | pages = 49–57 | date = 1989| doi = 10.1007/BF01579291 | pmid = 2540730 }}</ref> Ein use dey continue despite de rise of various accessible alternatives such as [[bicalutamide]] den [[cyproterone acetate]] plus more precise action den fewer side effects.<ref name="Burinkul_2021" /><ref name="Sehgal_2023" />
== References ==
<references />
== External links ==
[[Category:Translated from MDWiki]]
0l9fc1hu4rs07oz448f3no7uekuede0
114956
114955
2026-10-16T20:20:30Z
DaSupremo
9
Improve article
114956
wikitext
text/x-wiki
{{Databox}}
'''Spironolactone''', dem sell under de brand name '''Aldactone''' among odas, be classed as a [[diuretic]] [[medication]].<ref>{{Cite web |title=Australian Medicines Handbook |url=https://amhonline.amh.net.au/auth |access-date=12 May 2025 |website=amhonline.amh.net.au}}</ref> E fi be used to treat [[edema|fluid build-up]] secof [[hepatic cirrhosis|liver disease]] anaa [[kidney disease]].<ref name=AHFS2015>{{cite web|title=Spironolactone|url=https://www.drugs.com/monograph/spironolactone.html|publisher=The American Society of Health-System Pharmacists|access-date=24 October 2015|url-status=live|archive-url=https://web.archive.org/web/20151116054857/http://www.drugs.com/monograph/spironolactone.html|archive-date=16 November 2015}}</ref> E sanso be used to reduce risk of disease progression, hospitalization, den death secof sam types of heart failure.<ref name=":0">{{cite journal |vauthors=Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J |date=September 1999 |title=The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators |journal=The New England Journal of Medicine |volume=341 |issue=10 |pages=709–717 |doi=10.1056/NEJM199909023411001 |pmid=10471456}}</ref><ref>{{cite journal | vauthors = Li S, Zhang X, Dong M, Gong S, Shang Z, Jia X, Chen W, Yang J, Li J | title = Effects of spironolactone in heart failure with preserved ejection fraction: A meta-analysis of randomized controlled trials | language = en-US | journal = Medicine | volume = 97 | issue = 35 | article-number = e11942 | date = August 2018 | pmid = 30170387 | pmc = 6392615 | doi = 10.1097/MD.0000000000011942 }}</ref> Oda uses dey include acne den excessive hair growth insyd women, [[hypokalemia|low blood potassium]] wey no dey improve plus [[Potassium#Supplementation|supplementation]], high blood pressure wey be difficult to treat, den early puberty insyd boys.<ref name=AHFS2015/><ref>{{cite journal | vauthors = Friedman AJ | title = Spironolactone for Adult Female Acne | journal = Cutis | volume = 96 | issue = 4 | pages = 216–217 | date = October 2015 | pmid = 27141564 }}</ref><ref>{{cite book | vauthors = Maizes V | date = 2015 | title = Integrative Women's Health | publisher = Oxford University Press | edition = 2 | page = 746 | isbn = 978-0-19-021480-7 | url = https://books.google.com/books?id=uveJCgAAQBAJ&pg=PA746 }}</ref><ref>{{cite journal | vauthors = Sinnott SJ, Tomlinson LA, Root AA, Mathur R, Mansfield KE, Smeeth L, Douglas IJ | title = Comparative effectiveness of fourth-line antihypertensive agents in resistant hypertension: A systematic review and meta-analysis | journal = European Journal of Preventive Cardiology | volume = 24 | issue = 3 | pages = 228–238 | date = February 2017 | pmid = 27856806 | doi = 10.1177/2047487316675194 | url = https://researchonline.lshtm.ac.uk/id/eprint/3157879/1/Comparative%20effectiveness%20of%204th%20line%20anti-hypertensive%20agents%20in%20resistant%20hypertension%3B%20A%20systematic%20review%20and%20meta-analysis%20.pdf }}</ref> E sanso be used to [[Antiandrogen|block de effects]] of [[testosterone]] as a part of [[feminizing hormone therapy]].<ref name="WPATH-SOC8">{{cite journal |vauthors=Coleman E, Radix AE, Bouman WP, Brown GR, de Vries AL, Deutsch MB, Ettner R, Fraser L, Goodman M, Green J, Hancock AB, Johnson TW, Karasic DH, Knudson GA, Leibowitz SF, Meyer-Bahlburg HF, Monstrey SJ, Motmans J, Nahata L, Nieder TO, Reisner SL, Richards C, Schechter LS, Tangpricha V, Tishelman AC, Van Trotsenburg MA, Winter S, Ducheny K, Adams NJ, Adrián TM, Allen LR, Azul D, Bagga H, Başar K, Bathory DS, Belinky JJ, Berg DR, Berli JU, Bluebond-Langner RO, Bouman MB, Bowers ML, Brassard PJ, Byrne J, Capitán L, Cargill CJ, Carswell JM, Chang SC, Chelvakumar G, Corneil T, Dalke KB, De Cuypere G, de Vries E, Den Heijer M, Devor AH, Dhejne C, D'Marco A, Edmiston EK, Edwards-Leeper L, Ehrbar R, Ehrensaft D, Eisfeld J, Elaut E, Erickson-Schroth L, Feldman JL, Fisher AD, Garcia MM, Gijs L, Green SE, Hall BP, Hardy TL, Irwig MS, Jacobs LA, Janssen AC, Johnson K, Klink DT, Kreukels BP, Kuper LE, Kvach EJ, Malouf MA, Massey R, Mazur T, McLachlan C, Morrison SD, Mosser SW, Neira PM, Nygren U, Oates JM, Obedin-Maliver J, Pagkalos G, Patton J, Phanuphak N, Rachlin K, Reed T, Rider GN, Ristori J, Robbins-Cherry S, Roberts SA, Rodriguez-Wallberg KA, Rosenthal SM, Sabir K, Safer JD, Scheim AI, Seal LJ, Sehoole TJ, Spencer K, St Amand C, Steensma TD, Strang JF, Taylor GB, Tilleman K, T'Sjoen GG, Vala LN, Van Mello NM, Veale JF, Vencill JA, Vincent B, Wesp LM, West MA, Arcelus J |date=19 August 2022 |title=Standards of Care for the Health of Transgender and Gender Diverse People, Version 8 |url= |journal=International Journal of Transgender Health |volume=23 |issue=sup1 |pages=S1–S259 |doi=10.1080/26895269.2022.2100644 |issn=2689-5269 |pmc=9553112 |pmid=36238954 |doi-access=free}}</ref><ref name="HembreeCohen-KettenisGooren2017">{{cite journal |vauthors=Hembree WC, Cohen-Kettenis PT, Gooren L, Hannema SE, Meyer WJ, Murad MH, Rosenthal SM, Safer JD, Tangpricha V, T'Sjoen GG |date=November 2017 |title=Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline |journal=The Journal of Clinical Endocrinology and Metabolism |volume=102 |issue=11 |pages=3869–3903 |doi=10.1210/jc.2017-01658 |pmid=28945902 |s2cid=3726467 |doi-access=free}}</ref><ref name="Deutsch2016">{{cite web |date=17 June 2016 |title=Guidelines for the Primary and Gender-Affirming Care of Transgender and Gender Nonbinary People |url=https://transcare.ucsf.edu/sites/transcare.ucsf.edu/files/Transgender-PGACG-6-17-16.pdf |url-status=bot: unknown |archive-url=https://web.archive.org/web/20251005034705/https://transcare.ucsf.edu/sites/transcare.ucsf.edu/files/Transgender-PGACG-6-17-16.pdf |archive-date=5 October 2025 |access-date=24 April 2026 |publisher=Center of Excellence for Transgender Health |page=28 |edition=2nd |vauthors=Deutsch M |location=University of California, San Francisco}}</ref> Spironolactone usually be available insyd tablets, dem take [[oral administration|by mouth]], though topical forms sanso be available.<ref name=AHFS2015/>
Common [[side effect]]s dey include [[electrolyte abnormalities]], particularly [[hyperkalemia|high blood potassium]], nausea, vomiting, headache, rashes, den a decreased desire for sex.<ref name=AHFS2015/> Insyd those plus liver anaa kidney problems, extra care for be taken.<ref name=AHFS2015/>
If dem take during pregnancy, sam animal studies dey suggest say spironolactone fi affect de development of sex organs insyd babies.<ref name="pmid303522802">{{cite journal |vauthors=Liszewski W, Boull C |date=April 2019 |title=Lack of evidence for feminization of males exposed to spironolactone in utero: A systematic review |journal=Journal of the American Academy of Dermatology |volume=80 |issue=4 |pages=1147–1148 |doi=10.1016/j.jaad.2018.10.023 |pmid=30352280 |s2cid=53022388 |doi-access=free |title-link=doi}}</ref> While na dis no occur insyd de few human studies available,<ref name="pmid303522802" /><ref name="pmid271569052">{{cite journal |vauthors=Landau E, Amar L |date=June 2016 |title=Primary aldosteronism and pregnancy |journal=Annales d'Endocrinologie |volume=77 |issue=2 |pages=148–160 |doi=10.1016/j.ando.2016.04.009 |pmid=27156905}}</ref><ref>{{cite journal | vauthors = Deng N, Zhong J, Deng Z, Chen M, Yan L, Li H, Han J, Tao E | title = Case report: A pregnant woman accidental treated with spironolactone in mid-gestation | journal = Frontiers in Pharmacology | volume = 15 | article-number = 1404251 | date = 25 July 2024 | pmid = 39119600 | pmc = 11306061 | doi = 10.3389/fphar.2024.1404251 | doi-access = free }}</ref> women wey be pregnant anaa wey dey consider pregnancy for discuss spironolactone use plus dema doctor secof de theoretical risk.<ref name="pmid271569052" />
Spironolactone be a [[steroid]] wey dey [[receptor antagonist|block]] de effects of de [[hormone]]s [[aldosterone]], den to a lesser degree, testosterone, wey dey cause sam [[estrogen (medication)|estrogen]]-like effects.<ref name="Burinkul_2021">{{cite journal | vauthors = Burinkul S, Panyakhamlerd K, Suwan A, Tuntiviriyapun P, Wainipitapong S | title = Anti-Androgenic Effects Comparison Between Cyproterone Acetate and Spironolactone in Transgender Women: A Randomized Controlled Trial | journal = The Journal of Sexual Medicine | volume = 18 | issue = 7 | pages = 1299–1307 | date = July 2021 | pmid = 34274044 | doi = 10.1016/j.jsxm.2021.05.003 }}</ref>{{Unreliable source?|reason=primary|date=July 2024}}<ref name="Sehgal_2023">{{cite journal | vauthors = Sehgal I | title = Review of adult gender transition medications: mechanisms, efficacy measures, and pharmacogenomic considerations | journal = Frontiers in Endocrinology | volume = 14 | issue = | article-number = 1184024 | date = 2023 | pmid = 37476490 | pmc = 10355117 | doi = 10.3389/fendo.2023.1184024 | doi-access = free }}</ref><ref name="AHFS2015" /><ref name="Deedwania2014">{{cite book | vauthors = Deedwania PC | date = 30 January 2014 | title = Drug & Device Selection in Heart Failure | publisher = JP Medical Ltd | pages = 47– | isbn = 978-93-5090-723-8 | url = https://books.google.com/books?id=k8bUAgAAQBAJ&pg=PA47 | access-date = 5 July 2017 | archive-date = 7 October 2022 | archive-url = https://web.archive.org/web/20221007092257/https://books.google.com/books?id=k8bUAgAAQBAJ&pg=PA47 | url-status = live }}</ref> Spironolactone dey belong to a class of medications dem know as [[potassium-sparing diuretic]]s.<ref name="AHFS2015" />
Spironolactone be discovered insyd 1957, wey na dem introduce am insyd 1959.<ref name="OttowWeinmann2008">{{cite book | vauthors = Ottow E, Weinmann H | date = 9 July 2008 | title = Nuclear Receptors As Drug Targets | publisher = John Wiley & Sons | page = 410 | isbn = 978-3-527-62330-3 | url = https://books.google.com/books?id=iATfLbPgRugC&pg=PA410 | access-date = 28 May 2012 | archive-date = 21 June 2013 | archive-url = https://web.archive.org/web/20130621121614/http://books.google.com/books?id=iATfLbPgRugC&pg=PA410 | url-status = live }}</ref><ref name="Wermuth2008">{{cite book | vauthors = Wermuth CG | date = 24 July 2008 | title = The Practice of Medicinal Chemistry | publisher = Academic Press | page = 34 | isbn = 978-0-12-374194-3 | url = https://books.google.com/books?id=Qmt1_DQkCpEC&pg=PA34 | access-date = 27 May 2012 | archive-date = 21 June 2013 | archive-url = https://web.archive.org/web/20130621115634/http://books.google.com/books?id=Qmt1_DQkCpEC&pg=PA34 | url-status = live | author-link = Camille Georges Wermuth }}</ref><ref name="Sittig1988">{{cite book | vauthors = Sittig M | year = 1988 | title = Pharmaceutical Manufacturing Encyclopedia | publisher = William Andrew | page = 1385 | isbn = 978-0-8155-1144-1 | url = https://books.google.com/books?id=XCsJgUnclbcC&pg=PA1385 | access-date = 27 May 2012 | archive-date = 20 June 2013 | archive-url = https://web.archive.org/web/20130620225714/http://books.google.com/books?id=XCsJgUnclbcC&pg=PA1385 | url-status = live }}</ref> E dey on de [[WHO Model List of Essential Medicines|World Health Organization's List of Essential Medicines]].<ref name="WHO24th">{{cite book | vauthors = ((World Health Organization)) | year = 2025 | title = The selection and use of essential medicines, 2025: WHO Model List of Essential Medicines, 24th list | publisher = World Health Organization | doi = 10.2471/B09474 | doi-access = free | hdl = 10665/382243 | author-link = World Health Organization | location = Geneva | hdl-access = free | id = License: CC BY-NC-SA 3.0 IGO }}</ref> E be available as a [[generic medication]].<ref name=AHFS2015/> Insyd 2023, na e be de 52nd most commonly prescribed medication insyd de United States, plus more dan 12{{nbsp}}million prescriptions.<ref>{{cite web | title=Top 300 of 2023 | url=https://clincalc.com/DrugStats/Top300Drugs.aspx | website=ClinCalc | access-date=12 August 2025 | archive-date=12 August 2025 | archive-url=https://web.archive.org/web/20250812130026/https://clincalc.com/DrugStats/Top300Drugs.aspx | url-status=live }}</ref><ref>{{cite web | title = Spironolactone Drug Usage Statistics, United States, 2014 - 2023 | website = ClinCalc | url = https://clincalc.com/DrugStats/Drugs/Spironolactone | access-date = 18 August 2025 }}</ref> Spironolactone get a history of use insyd de trans community.<ref>{{cite journal | vauthors = Prior JC, Vigna YM, Watson D | title = Spironolactone with Physiological Female Steroids for Presurgical Therapy of Male-To-Female Transsexualism | journal = Archives of Sexual Behavior | volume = 18 | issue = 1 | pages = 49–57 | date = 1989| doi = 10.1007/BF01579291 | pmid = 2540730 }}</ref> Ein use dey continue despite de rise of various accessible alternatives such as [[bicalutamide]] den [[cyproterone acetate]] plus more precise action den fewer side effects.<ref name="Burinkul_2021" /><ref name="Sehgal_2023" />
== References ==
<references />
== External links ==
{{Commons}}
{{Authority control}}
[[Category:Spironolactone| ]]
[[Category:3β-Hydroxysteroid dehydrogenase inhibitors]]
[[Category:5α-Reductase inhibitors]]
[[Category:11β-Hydroxylase inhibitors]]
[[Category:17β-Hydroxysteroid dehydrogenase inhibitors]]
[[Category:21-Hydroxylase inhibitors]]
[[Category:Acetate esters]]
[[Category:Aldosterone synthase inhibitors]]
[[Category:Anti-acne preparations]]
[[Category:Antimineralocorticoids]]
[[Category:Cholesterol side-chain cleavage enzyme inhibitors]]
[[Category:CYP17A1 inhibitors]]
[[Category:Hair loss medications]]
[[Category:Hair removal]]
[[Category:Lactones]]
[[Category:Pregnane X receptor agonists]]
[[Category:Pregnanes]]
[[Category:Prodrugs]]
[[Category:Progestogens]]
[[Category:Selective estrogen receptor modulators]]
[[Category:Spiro compounds]]
[[Category:Spirolactones]]
[[Category:Steroidal antiandrogens]]
[[Category:Thioesters]]
[[Category:World Health Organization essential medicines]]
[[Category:Translated from MDWiki]]
r6l13mmapq16chlahm2jsh6jjnuiimm
Category:Spironolactone
14
31045
114957
2026-10-16T21:14:50Z
DaSupremo
9
Fresh category
114957
wikitext
text/x-wiki
phoiac9h4m842xq45sp7s6u21eteeq1
Category:3β-Hydroxysteroid dehydrogenase inhibitors
14
31046
114958
2026-10-16T21:15:30Z
DaSupremo
9
Fresh category
114958
wikitext
text/x-wiki
phoiac9h4m842xq45sp7s6u21eteeq1
Category:17β-Hydroxysteroid dehydrogenase inhibitors
14
31047
114959
2026-10-16T21:18:10Z
DaSupremo
9
Fresh category
114959
wikitext
text/x-wiki
phoiac9h4m842xq45sp7s6u21eteeq1
Category:Aldosterone synthase inhibitors
14
31048
114960
2026-10-16T21:19:57Z
DaSupremo
9
Fresh category
114960
wikitext
text/x-wiki
phoiac9h4m842xq45sp7s6u21eteeq1
Category:Lactones
14
31049
114961
2026-10-16T21:20:10Z
DaSupremo
9
Fresh category
114961
wikitext
text/x-wiki
phoiac9h4m842xq45sp7s6u21eteeq1
Category:Progestogens
14
31050
114962
2026-10-16T21:21:12Z
DaSupremo
9
Fresh category
114962
wikitext
text/x-wiki
phoiac9h4m842xq45sp7s6u21eteeq1
Category:Selective estrogen receptor modulators
14
31051
114963
2026-10-16T21:21:41Z
DaSupremo
9
Fresh category
114963
wikitext
text/x-wiki
phoiac9h4m842xq45sp7s6u21eteeq1
Category:Spirolactones
14
31052
114964
2026-10-16T21:22:07Z
DaSupremo
9
Fresh category
114964
wikitext
text/x-wiki
phoiac9h4m842xq45sp7s6u21eteeq1
Category:Steroidal antiandrogens
14
31053
114965
2026-10-16T21:22:19Z
DaSupremo
9
Fresh category
114965
wikitext
text/x-wiki
phoiac9h4m842xq45sp7s6u21eteeq1
Category:Thioesters
14
31054
114966
2026-10-16T21:22:50Z
DaSupremo
9
Fresh category
114966
wikitext
text/x-wiki
phoiac9h4m842xq45sp7s6u21eteeq1
Folate
0
31055
114967
2026-10-17T11:49:19Z
DaSupremo
9
Created by translating the page [[:mdwiki:Special:Redirect/revision/1502068|Folate]] to:gpe #mdwikicx
114967
wikitext
text/x-wiki
[[Category:Translated from MDWiki]]
r0gf7axtnvt68k0p85plnlehx64o08u